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Avian coronavirus infectious bronchitis virus (IBV) and influenza virus are 
two respiratory viruses that have great impact on veterinary and human health 
globally. The two respiratory viruses described in this thesis share many 
commonalities on the molecular mechanisms of entry in host cells. Following cell 
surface attachment via receptor binding, these enveloped viruses need to be 
internalized into subcellular compartments to initiate fusion and uncoating. Although 
often studied in certain prototypical cell types, many details of attachment and entry 
pathways are overlooked in more in vivo-relevant cell types. 
Despite many speculations on its receptor usage, the authentic IBV receptor 
has not been discovered although the attachment factor sialic acid is documented. 
When I expressed DC-SIGN and L-SIGN, the C-type lectins, in mammalian cells, I 
discovered that IBV are able to infect these non-permissive cells that are usually 
refractory to IBV infection. In addition, the infection in DC-SIGN-expressing cells is 
independent on the level of sialic acid on the cell surface.  When I examed whether 
sialic acid also plays a role in IBV infection of chicken peripheral blood derived 
monocytes (chPBMCs), cells that potentially harbor the authentic proteinaceous 
receptor for IBV, I unexpectedly found that the established attachment factor sialic 
acid does not play a critical role in the IBV infection in chPBMC. To further evaluate 
 the entry pathways utilized by IBV in chPBMCs, I examined the IBV infection in the 
presence chemical inhibitors used to disrupt endocytic components. Using 
immunofluorescence microscopy, I identified that caveolae-dependent endocytosis 
and macropinocytosis pathways were used by IBV entry in chPBMCs.  
In a similar chemical and molecular approach, in the presence of endocytic 
inhibitors and dominant- negative proteins implicated in the endocytic pathways, I 
evaluated the influenza virus entry in polarized epithelial cells-- Madin-Darby canine 
kidney (MDCK) cells, a model for the cells at primary sites of influenza infection in 
vivo. My study showed that in polarized MDCK II cells, influenza virus has a 
differential utilization for CME pathway and requires Eps15 protein for entry 
In all, these studies of coronavirus and influenza virus entry provide a clearer 
understanding of the molecular mechanisms involved in enveloped virus entry into 
host cells. The results of this study will enrich our knowledge of enveloped virus 
pathogenesis.  
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CHAPTER 1 
INTRODUCTION 
 
Avian coronavirus infectious bronchitis virus 
and 
influenza virus 
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1.1.1 Avian Coronavirus infectious bronchitis virus: overview 
As the first member of the Coronaviridae to be discovered, avian coronavirus 
infectious bronchitis virus has almost 80 years of history in virological research and 
poultry science. In the 1930’s, Schalk and Hawn first described a contagious respiratory 
disease, infectious bronchitis (IB), in a flock of baby chicks in the United States (Schalk, 
1931). The disease spread among chickens rapidly and caused high mortality. In 1936, 
Beach and Schalm demonstrated that IB was caused by a novel virus, which was named 
Infectious bronchitis virus (IBV) (Beach, 1936). In the following year, Beaudette 
successfully propagated the virus in embryonated eggs and discovered a lab-adapted 
strain of IBV (Beaudette, 1937). IBV research has provided insights into other 
subsequently discovered coronaviruses that are important for both veterinary and human 
health (Figure 1.1.).  
Although other members of the coronavirus family have wide tropism and infect 
many tissue types, IBV mainly infects epithelia of the respiratory tract and causes 
respiratory disease in the chicken host. However, many studies have discovered that IBV 
can also replicate at comparatively lower levels and cause pathology in other tissues such 
as testes, oviducts, and alimentary tract (Raj and Jones, 1997). Clinical signs include, but 
are not limited to, coughing, sneezing, nasal discharge, loss of appetite, and reduction of 
egg laying (Saif, 2003b). Some strains such as Massachusetts 41 (M41) and B1648 can 
cause major or minor nephritis in both naturally infected or experimentally infected 
chickens (Lambrechts et al., 1993).   
IBV has caused great economic loss in the poultry industry around the globe by 
reducing productivity and increasing mortality in chickens. Chickens of all ages are  
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Figure 1.1. Phylogenetic tree of coronaviruses. The phylogenetic analysis was performed 
by using coronavirus spike protein sequences from GenBank. The accession numbers for 
the sequences used are PEDV, porcine epidemic diarrhea virus (ABI30278.1); TGEV-
Purdue, porcine transmissible gastroenteritis virus (ABG89335.1); FCoV-79-1146, feline 
coronavirus (YP_004070194.1); HCoV-229E, human coronavirus (AAG48592.1); 
HCoV-NL63-Amsterdam, human coronavirus ( AAS58177.1); BatCov-
HKU2(ABQ57216.1); HCoV-OC43-VR-759, human coronavirus (AAT84354.1); BCoV-
Quebec, bovine coronavirus ( AAL40400.1); Equine Cov(AAQ67205.1); MHV-A59, 
murine hepatitis virus (AAU06356.1); HCoV-HKU1, human coronavirus (AAT98580.1); 
SARS-CoV-Tor2, severe acute respiratory syndrome coronavirus (NP_828851.1); IBV-
M41( AAW33786.1); Turkey-Cov(ACV87265.1); Beluga Whale coronavirus 
SW1(ABW87820.1) ; Bulbul Cov HKU11-934 (ACJ12035.1); Thrush Covs HKU12-600 
(YP_002308497.1); Munia Cov HKU13-3514(YP_002308506.1). The sequence 
alignment and the tree were generated by ClustalX 2.1 with the Neighbor-Joining 
algorithm. Scale bars represent the estimated number of substitutions per site. 
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susceptible to the disease; however, the severity of the disease can vary among different 
breeds of chicken and among different strains of IBV contracted (Cavanagh et al., 2007). 
IBV infections are currently under-controlled with live virus vaccination of major 
circulating strains. However, cross-protection for new recombined strains is fairly poor 
(Hofstad, 1981). Outbreaks of IBV frequently occur in vaccinated chicken flocks (Liu 
and Kong, 2004). Study and surveillance of IBV remains an active area in poultry 
science. 
 
1.1.2 Molecular organization and life cycle of IBV 
The family Coronaviridae is composed of viruses with positive single-strand RNA 
genomes and they are enveloped. Virion size ranges from 100 to 120 nm in diameter. The 
characteristic projections cover the surface of the virus, giving its name “corona” 
(meaning “crown” in Greek). The virion contains the nucleocapsid protein (N), which 
associates with the RNA genome, the surface glycoprotein spike (S), numerous copies of 
the integral membrane protein (M), and a smaller number of envelope proteins (E).  In 
contrast to the Betacoronavirus, IBV does not have hemagglutinin esterase (HE) protein 
on its surface (Figure. 1.2.).  
Like all other animal viruses, IBV starts its life cycle by attachment to the 
receptor on the host cell membrane via spike protein. It enters the cell through an 
endocytic mechanism and the fusion with host cell membrane depends on low-pH 
activation (Chu et al., 2006a). The viral nucleocapsid is then released into the cytosol. 
The RNA genome is subsequently uncoated and ready for translation and transcription. 
However, the detailed processes of replication are unknown (Howley, 2007). The  
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Figure 1.2. Molecular organization of IBV. The virion contains the nucleocapsid 
protein (N), which associates with the RNA genome, the surface glycoprotein spike (S), 
numerous copies of the integral membrane protein (M), and a smaller number of 
envelope proteins (E).  
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replicase-transcriptase proteins are first directly translated into two polypeptides pp1a and 
pp1ab. These polypeptides are then cleaved by virus-encoded proteinases into 16 viral 
proteins (Seybert et al., 2000). With other viral proteins and cellular proteins, the 
replicase-transcriptase proteins form replication-transcription complexes (RTC), which 
synthesize genomic and sub-genomic RNA (Prentice et al., 2004). The viral complex first 
synthesizes the negative strand of the RNA genome. Then by using the negative strand 
RNA as a template, subgenomic mRNAs are transcribed for downstream production of 
viral proteins including N, S, M, and E protein (Sawicki et al., 2007). The N protein and 
the newly synthesized RNA form nucleocapsids. Other structural proteins are inserted 
into and processed in the endoplasmic reticulum. The virion undergoes “internal 
budding” from the endoplasmic reticulum-Golgi intermediate compartments (ERGIC) 
and is released by an exocytic mechanism (Klumperman et al., 1994; Tooze et al., 1987). 
Some S proteins may travel to the host cell surface and mediate syncytium formation 
with neighboring cells to spread infection (Figure 1.3.) 
 
1.1.3 IBV strains  
Due to continuous global effort in IBV surveillance, over 1400 IBV strains have 
sequence information in the Virus Pathogen Resources Database (VIPRBRC). Currently, 
there are three major serotypes circulating in the U.S. represented by: M41, Connecticut 
46 (Conn46), and Arkansas 99 (Ark99). Although vaccination against the major 
serotypes is common for poultry, it generally gives poor cross-protection to other 
serotypes as well as reduced protection to new variants that arise from mutation or 
recombination.  
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Figure 1.3. Life cycle of IBV. The IBV particle first attaches to the host cell via an 
unknown receptor protein. After internalization, the virus fuses with endosome 
membrane via its spike protein. The viral RNA is then released to the cytoplasm for 
translation to polyproteins. After proteolytic cleavage, the viral replicase-transcriptase 
proteins form replication-transcription complexes (RTC), where genomic and 
subgenomic RNA are synthesized. Structural and non-structural proteins are processed at 
the endoplasmic reticulum (ER). The progeny virions are assembled at the ER-Golgi 
intermediate compartment (ERGIC) and released via an exocytosis pathway. 
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The S1 subunit of IBV spike protein harbors specific epitotes that can induce neutralizing 
antibodies (Cavanagh et al., 1984; Cavanagh et al., 1986). Serotypes of IBV are 
distinguished by virus neutralizing assays (Cowen and Hitchner, 1975; Hopkins, 1974). 
Currently there are more than 20 serotypes of IBV (Gelb et al., 1991). Different serotypes 
of IBV can vary from 20% to 50% at the amino acid sequence level in the S1 subunit 
(Cavanagh, 2007). The genotype derived from the IBV S1 hypervariable region sequence 
correlates with serotyping in cross-neutralization assays (Wang and Huang, 2000). 
Like many RNA viruses, the unique RNA replication machinery (such as the 
error-prone RNA-dependent RNA polymerase) and mechanisms (such as “template-
switching”) contribute to the genetic diversity of coronaviruses. In addition to the high 
mutation rate, there have been many pieces of evidence of recombination among different 
strains of IBV, both experimentally and in the field (Cavanagh et al., 1992; Chen et al., 
2010b; Estevez et al., 2003; Jackwood et al., 2010; Jia et al., 1995; Kottier et al., 1995a, 
b; Kuo et al., 2010; Kusters et al., 1990; Lee and Jackwood, 2000; Mardani et al., 2010; 
Thor et al., 2011; Wang et al., 1993; Wang et al., 1997). Recombination near the S1 
subunit could lead new serotypes or new strains of IBV in the field. (Wang et al., 1993) 
The lab-adapted strain Beaudette was generated by serial passage in embryonated 
eggs. It has 95% sequence similarity at the amino acid level with its parental strain M41. 
The Beaudette strain is able to induce severe lesions and stunted growth of embryos when 
inoculated into 11-day-old embryonated eggs. It can also replicate to high titers in 
tracheal organ culture. Interestingly, the Beaudette strain does not cause symptoms when 
inoculated into chickens while the parental M41 strain causes severe respiratory 
symptoms and is able to replicate in multiple organs, including kidneys. 
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1.1.4 Laboratory host models for IBV 
Chicken embryonated eggs have been used to cultivate IBV since the 1930’s and 
have remained the only system to propagate the virus after isolation. Typically, IBV is 
inoculated into the allantoic chamber of a 10-11 day old chicken embryonated egg. 
Approximately 2 days post inoculation, virus can be recovered from allantoic fluid of the 
infected egg. IBV preparations from embryonated eggs produce large amounts of 
defective interfering particles. The infected chicken embryos display stunting 
characteristics compared to healthy embryos at the same development stage (Figure 1.2.). 
However, the abnormality of the IBV-infected embryo does not reflect the pathogenicity 
of the virus strain inoculated since the Beaudette strain, an apathogenic IBV strain in 
chicken, can also induce such abnormality. IBV can become attenuated, for example, in 
the case of Beaudette, in chickens by serial passage in embryonated eggs. The virus 
becomes highly lethal to chicken embryos yet is non-infectious to adult chickens 
(Beaudette, 1937).  
The egg infectious dose 50 assay, which is the “gold standard” for titering IBV, 
usually does not correlate with the tissue infectious dose 50 assay using primary chicken 
kidney cells, which are the only cell culture system commonly used by IBV researchers. 
However, the reason for the discrepancy between the two tittering methods remains 
unclear. Another commonly used cell type for IBV field strains or clinical strains is 
chicken embryonated fibroblasts (Table 1.1). Other primary chicken derived cell lines are 
relatively inconvenient for general laboratory use. Beaudette remains the only strain that 
can infect a variety of mammalian cell lines thus allowing it to be used as an in vitro 
infection model. Mammalian cell lines expressing C-type lectin DC/L-SIGN are  
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Figure 1.4. Comparison of healthy chicken embryos and IBV-M41 infected chicken 
embryos. 10-day-old chicken embryonated eggs were either mock infected (left) or 
infected with IBV-M41 virus (right). Embryos were euthanized by incubating the eggs at 
4°C over night and were examined post-mortem. 
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Table 1.1. Cell lines susceptible to IBV 
 
 Cell line or cell type Susceptibility to 
IBV strain 
Reference 
Chicken kidney cells All strains (Otsuki et al., 
1979a) 
Chicken embryonated fibroblasts All strains (Otsuki et al., 
1979b) 
Chicken embryo related cell line M41 (Ferreira et al., 
2003) 
Avian origin 
Primary chicken tracheal epithelial 
cells 
2575/98, 2296/95 (Shen et al., 2010) 
3T3-DCSIGN cell line and other 
DC/L-SIGN expressing cell lines 
M41, Cal99, Conn46, 
Iowa609, Gray, 
Iowa97, JMK 
(Zhang et al., 
2012) 
Vero (African green monkey 
kidney) cells  
Beaudette (Cunningham et 
al., 1972) 
Non-avian 
origin 
BHK-21 (Baby hamster kidney) 
cells  
Beaudette (Otsuki et al., 
1979b) 
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also susceptible to IBV field strains infections. These cells will be discussed in Chapter 2 
of this thesis. 
 
1.1.5 IBV spike protein as a pathogenesis determinant 
The spike glycoprotein S is a 180 kDa glycoprotein (Figure 1.3.). It has two 
subunits: the N-terminal S1 subunit and the C-terminal S2 subunit. The spike protein S1 
subunit allows the virus to bind to the receptor or attachment factor on the host cell 
surface (Koch et al., 1990; Koch and Kant, 1990). The S2 subunit mediates the fusion of 
the viral membrane with the endosomal membrane to release the viral RNA into the 
cytoplasm. The S1 subunit is the major neutralizing antibody inducer in the host. This is 
evidenced by the lack of protective immunity or virus neutralizing antibodies in chickens 
immunized with IBV virus without an S1 subunit while the S2 subunit was retained 
(Cavanagh and Davis, 1986). The S protein is considered the major determinant of 
pathogenicity and cellular tropism of coronaviruses. Using reverse genetics, Cassis and 
coworkers demonstrated that the IBV Beaudette strain, which is pan-tropic, loses the 
ability to infect Vero cells and BHK cells, after having its spike protein replaced with the 
spike protein from the IBV-M41 strain, the tropism of which is strictly limited to primary 
chicken kidney cells (Casais et al., 2003).  
The coronavirus S glycoprotein is synthesized as a single polypeptide chain, 
which oligomerises into trimers in the endoplasmic reticulum of the host cell and are 
processed in the Golgi apparatus (Delmas and Laude, 1990). The S protein is highly 
glycosylated with N-linked high mannose (Cavanagh, 1983). Sequence analysis with 
NetNGlyc 1.0 server shows that S protein harbors over 30 potential N-linked 
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glycosylation sites. These glycosylation sites may be involved in interactions with 
cellular components, as is the case for SARS-CoV, in which 7 N-linked glycosylation 
sites of the S protein are critical for DC/L-SIGN mediated entry of SARS-CoV (Han et 
al., 2007). 
Proteolytic cleavage of S protein is an important feature of coronaviruses and 
other enveloped viruses such as influenza virus and respiratory syncytial virus. The S 
protein of IBV is cleaved into S1 and S2 subunits and is further proteolytically processed 
at the S2' cleavage site (Belouzard et al., 2009). The S1/S2 cleavage site does not 
correlate with serotype or pathogenicity (Jackwood et al., 2001). The second cleavage 
site within the S2 subunit is associated with furin-dependent viral entry and syncytia 
formation in vitro and is critical for cell culture infectivity (Yamada and Liu, 2009). 
However, the involvement of the second cleavage site of IBV S protein in vivo is not 
evident.  
 
1.1.6 Receptor and attachment factors for IBV 
The ability of IBV to infect various tissues in chickens may be linked to the 
receptor distribution in these tissues. The unique features of IBV tropism are often 
neglected at the molecular level as many studies use the pan-tropic Beaudette as a model 
virus for IBV. The apathogenic Beaudette strain clearly has a modified and distinct 
tropism compared to its pathogenic field strain counterpart M41. 
The receptor for IBV has not been identified. There was speculation that feline 
aminopeptidase N (fAPN), which can serve as a universal receptor for 
Alphacoronaviruses, is the receptor for IBV, based in part on the ability of IBV to infect  
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Figure 1.5. Model of SARS-CoV spike. Spike protein structural model is generated in 
Pymol with 1T7G (Protein Data Bank). Magenta portion represents the S1 subunit and 
green portion represents the S2 subunit. 
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feline kidney cells (Miguel et al., 2002). However, expression of fAPN fails to rescue 
infection by a panel of field isolates of IBV in a non-permissive cell line indicates that 
fAPN is not a functional receptor for IBV (Chu et al., 2007).  
There have been several studies showing that the tissue tropism of IBV may be 
linked to the distribution of its attachment factor, sialic acid, which is present on the cell 
surface of various enteric tissues. Winter and coworkers demonstrated that by treating 
Vero cells with neuraminidase, the pan-tropic IBV Beaudette strain is no longer able to 
infect Vero cells (Winter et al., 2006). Wickramasinghe et al further demonstrated that 
the S1 of IBV M41 strain exhibits sialic acid-dependent binding to chicken respiratory 
tract tissue sections by histochemistry. In addition, S1 of M41 is able to bind to a 
particular sialic acid-containing glycan: [Neu5Acα2, 3Galβ1, 3(Neu5Acα2,3Galβ1,4)-
GlcNAc] on a glycan array (Wickramasinghe et al., 2011). A heparan sulfate (HS) 
binding site (SRRKRS or SRRRRS) within the S2 subunit of the Beaudette S protein 
may be used as a selective receptor for Beaudette virus entry to host cells (Madu et al., 
2007). However, this sequence is only found in the S protein of Beaudette strain, which 
may explain for the extended host range of Beaudette in comparison to M41.  
 
1.1.7   DC-SIGN: a novel viral receptor? 
Dendritic Cell-Specific Intercellular adhesion molecule-3-Grabbing Non-integrin 
(DC-SIGN) and its closely related Liver/lymph node-specific ICAM-3 grabbing non-
integrin (L-SIGN) are calcium-dependent lectins. DC-SIGN and L-SIGN are type-II 
transmembrane proteins. The structure consists of a small cytoplasmic tail, a 
transmembrane domain, and an ectodomain. The extracellular-oriented ectodomain has a 
 16 
carbohydrate recognition domain and neck repeats, in which DC-SIGN and L-SIGN 
differ the most (Feinberg et al., 2001). DC-SIGN is mainly expressed on myeloid-lineage 
dendritic cells (DC) in the lymphoid tissues (but not on Langerhan cells) and 
macrophages (Soilleux, 2003). L-SIGN, which shares approximately 77% sequence 
homology with DC-SIGN, mainly express on liver sinusoidal endothelial cells (Bashirova 
et al., 2001) and endothelial cells in the lymph node and placenta (Braet and Wisse, 
2002). The DC-SIGN was first discovered to be important in human immunodeficiency 
virus type 1 (HIV-1) pathogenesis (Geijtenbeek et al., 2000). This lectin is believed to 
interact with the HIV-1 surface glycoprotein gp120 and enables capturing and 
transporting of the virus particle from the mucosal infection site to secondary lymphoid 
tissues (Geijtenbeek et al., 2000). DC-SIGN is also able to enhance HIV-1 infection in cis 
as an attachment factor (Pei et al., 2001). With a similar structure to DC-SIGN, L-SIGN 
is able to capture HIV-1 in the same manner. Many enveloped viruses such as Ebola 
virus, hepatitis C virus, and Sindbis virus also have been shown to be interacting with 
DC-SIGN and/or L-SIGN presumably via interaction with high-mannose glycoproteins 
on the viral particles (Alvarez et al., 2002; Klimstra et al., 2003; Navarro-Sanchez et al., 
2003; Pohlmann et al., 2003). For coronaviruses, there have been increasing numbers of 
reports demonstrating a role for human DC-SIGN and/or L-SIGN in pathogenesis of 
SARS coronavirus, human coronavirus-229E, human coronavirus-NL63, as well as feline 
coronavirus by enhancement of infection (Marzi et al., 2006; Marzi et al., 2004; Regan 
and Whittaker, 2008; Yang et al., 2004).  
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1.1.8 Endocytosis of IBV 
Many enveloped viruses exploit the cellular mechanism of endocytosis to gain 
entry into host cells. A virus can use multiple entry pathways to bring its genetic material 
into the cytoplasm. However, the choice of a particular pathway can be cell-type 
dependent. Coronaviruses use a variety of endocytic pathways to enter host cells 
(Table1.2.). The IBV Beaudette strain enters BHK-21 cells via a low pH dependent 
endocytic pathway (Chu et al., 2006a; Chu et al., 2006b). However, the exact pathway 
used by IBV, especially in chicken cell lines, remains unknown. 
 
1.1.9 Apoptosis of IBV infected cells  
In vitro, IBV causes extensive cytopathic effect in permissive cells. Vero cells 
infected by the Beaudette strain form multi-nucleared syncytia and eventually round up 
and detach from the tissue culture. Apoptosis of Vero cells induced by infection with the 
Beaudette strain is caspase-dependent and is inhibited by the pan-caspase inhibitor z-
VAD-FMK (Liu et al., 2001). In addition, IBV induces cell cycle arrest in Vero cells and 
H1299 cells that are devoid of p53, a mediator of apoptosis (Li et al., 2007a). IBV 
infection in chickens is usually associated with lesions in the trachea, kidney, and other 
organs. However, the cytopathic effects induced by IBV in vivo and in chicken cells are 
yet to be characterized. 
 
1.1.10 Perspectives 
As the first described coronavirus, IBV still remains mysterious at the molecular 
level and at the clinical level; numerous questions are still puzzling researchers: what is  
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Table 1.2. Coronavirus endocytic pathways 
 
  Virus Cell type Endocytic pathway Reference 
HCoV 
229E 
Human 
fibroblasts 
Caveolae-mediated pathway (Nomura et 
al., 2004) 
Alpha 
coronavirus 
  FIPV Feline 
monocytes 
Clathrin-independent pathway, Caveolae-
independent pathway 
(Van 
Hamme et 
al., 2008) 
SARS-
CoV 
HepG2, Cos7 Clathrin-mediated pathway (Yang et 
al., 2004) 
(Inoue et 
al., 2007) 
SARS-
CoV 
Vero E6 Clathrin-independent pathway, Caveolae-
independent pathway 
(Wang et 
al., 2008) 
MHV 
A59 
murine cells Clathrin-mediated pathway, cholesterol-
dependent pathway 
(Choi et al., 
2005; Eifart 
et al., 2007; 
Thorp and 
Gallagher, 
2004) 
Beta 
coronavirus  
  
  
MHV-
2 
DBT cells Clathrin-mediated pathway independent of 
Eps15 
(Pu and 
Zhang, 
2008) 
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its putative receptor; how does the virus interact with its receptor; what type of antigen 
presenting cells are the major inducers of the adaptive immune response; and so on. IBV 
and other coronaviruses received increased attention after the human outbreak of SARS 
coronavirus in 2003, which became a new model for emerging viruses. Studies on IBV 
not only benefit the poultry industry but also allow researchers to gain insight in the 
evolution of coronaviruses. Development of vaccines for IBV may also give new 
perspectives to future vaccine design for other human coronaviruses.  
 
 
1.2.1   Influenza virus characteristics and life cycle of influenza virus 
Influenza virus is a common pathogen of the upper respiratory tract of humans 
and a broad range of animals including birds and other mammals. Influenza virus can 
cause mild to severe and occasionally lethal disease. Pandemic influenza occurs 
irregularly; notable pandemics include the 1918 Spanish flu and the 2009 H1N1 flu. Over 
200,000 influenza-associated hospitalizations occur annually in the United States 
(Thompson et al., 2004).  
Influenza virus, a member of the Orthomyxoviridae, is enveloped, and has a 
negative-sense, segmented RNA genome. The virus includes three types: A, B and C. 
Among the three types, influenza A viruses are the most widespread and infect a variety 
of animal species; influenza B causes only mild disease in humans, while influenza C can 
infect humans and pigs causing mild disease signs. The eight RNA segments of influenza 
virus A are associated with many copies of the nucleoprotein (NP) and heterotrimeric 
polymerase complexes (PB1, PB2, and PA), which form the viral nucleoproteins 
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(vRNPs). The vRNPs are surrounded by a layer of matrix protein (M1), which connects 
vRNPs to the virus envelope. Two types of glycoproteins are inserted into the lipid 
bilayer viral membrane: hemagglutinin (HA) and neuraminidase (NA). The receptor for 
influenza A virus has been well characterized. The specific conformation of the sialic 
acid linkage (SAα-2, 3 vs. SAα-2, 6) controls species tropism of the virus. Avian 
influenza viruses preferentially bind to sialic acid with 2, 3 linkages to galactose. On the 
other hand, human influenza viruses preferentially bind to sialic acid with 2, 6 linkages to 
galactose (Medina and Garcia-Sastre, 2011). During virus infection, the virion binds to 
the host cell surface receptor via HA, followed by endocytosis into endosomal 
compartments. The acidic environment in the endosomes induces conformational change 
in the HA, and as a result, fusion peptides residing in the HA2 are exposed, triggering 
viral fusion with the endosomal membrane. Subsequently, due to the ion channel activity 
of M2 proteins anchored in the viral envelope and the matrix shell, the viral components 
inside the particle are exposed to the low pH of the endosome, disrupting the interaction 
of M1 and vRNPs. Uncoated nucleoproteins are released into the cytosol and then are 
transported into the nucleus to initiate viral protein synthesis. The newly synthesized viral 
proteins and genome are targeted to the host plasma membrane, where viral components 
are assembled into virions, which bud into the extracellular environment to produce 
progeny viruses (Pinto et al., 1992; Whittaker, 2001; Yoshimura and Ohnishi, 1984) 
 
1.2.2   Endocytosis pathways  
Endocytosis is a cellular process that involves the internalization of proteins, 
lipids, and soluble molecules from the cell surface or the extracellular space. Most 
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viruses take advantage of the cellular endocytic events to gain entry into host cells 
(Sieczkarski and Whittaker, 2002a). After being endocytosed, viruses can initiate 
replication once they penetrate or fuse with the endosomal membrane (Marsh and 
Pelchen-Matthews, 2000). Due to the diversity of ligands and membrane components, 
along with their different ultimate destinations, cells possess more than one endocytic 
pathway to accomplish trafficking. As obligate intracellular parasites, viruses have 
evolved with host cells and have gained the ability to hijack multiple cellular endocytic 
pathways. 
Clathrin-dependent endocytosis is one of the best-characterized endocytic 
pathways. Cellular receptors and membrane proteins with cytoplasmic tyrosine motif 
(YXXΦ) or dileucine internalization motifs are recognized by the adaptor protein 2 (AP-
2) (Kozik et al., 2010). With other accessory proteins such as Eps15, Epsin1, 
Synaptojanin1, AP-2 recruits clathrin from the cytosol reservoir to form clathrin-coated 
pits. The clathrin-coated pits are then pinched off at the neck by the small GTPase 
dynamin and other proteins to form clathrin-coated vesicles (Marsh and McMahon, 
1999). After being endocytosed, the clathrin coat is disassembled and is recycled. The 
uncoated vesicles fuse with early endosomes, from which the internalized receptors or 
membrane proteins are further delivered to different destinations (Conner and Schmid, 
2003; Marsh and McMahon, 1999). To date, the transferrin receptor and low-density 
lipoprotein (LDL) receptor are the best examples for studying endocytosis dependent on 
functional clathrin. Specific non-functional forms of cellular proteins have been 
developed to selectively block clathrin-dependent endocytosis. For example the dominant 
negative forms of regulatory protein Eps15 and clathrin hub fragments have been widely 
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used to exclusively inhibit clathrin-mediated endocytosis (Benmerah et al., 2000).  
Macropinocytosis is an actin-dependent, dynamin-independent endocytic process 
that is involved in fluid uptake and large particles. Unlike phagocytosis, which is 
restricted to immune cells such as macrophages and dendritic cells, macropinocytosis can 
take place in all cell types upon stimulations (Swanson and Watts, 1995). As a unique 
endocytic process that does not form invaginations on the cell surface, macropinocytosis 
relies on the ruffling and blebbing of the plasma membrane. Upon growth factor 
stimulation and trigger of underlying receptor tyrosine kinase signaling pathways such as 
Pak1, Protein kinase C, Src kinase, actin filament dynamics of polymerization and 
turnover are changed and membrane rufflings are formed (Kasahara et al., 2007; Liberali 
et al., 2008; Mercer and Helenius, 2009). Small GTPases such as Ras family GTPases, 
Rac1, Rab5, Arf6 are involved in modulation of ruffle formations (Lanzetti et al., 2004; 
Ridley et al., 1992). Viruses and large particles are internalized with other fluid and 
solutes by macropinocytosis upon stimulation. In this case, receptor for viruses may not 
be required. Interestingly, adenovirus, which is endocytosed via a clathrin-dependent 
pathway, was found to stimulate macropinocytosis of resting cells after being 
internalized. However, the upregulated macropinocytosis was not employed for 
facilitating viral entry, but instead for virus escaping from the endosomes by an unknown 
mechanism (Meier and Greber, 2004).  
 
1.2.3   Endocytic pathways of influenza virus in non-polarized cells 
In early studies of influenza entry in MDCK cells, electron micrographs showed 
virus particles in coated pits and coated vesicles. These data suggest that influenza virus 
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can enter host cells via clathrin-dependent endocytosis (Matlin et al., 1981). Later studies 
in the influenza field demonstrated a role of dynamin-dependent endocytosis of influenza 
virus entry by examining the effect of dominant-negative dynamin on influenza virus 
entry in Mv-1 mink lung cells (Roy et al., 2000). Electron micrographs also revealed that 
influenza virus particles reside in non-coated invaginations in the membrane as well as 
smooth vesicles inside the cell (Morgan et al., 1954). These smooth vesicles were not 
seen in Semliki Forest virus (SFV) entry or vesicular stomatitis virus (VSV) entry. This 
indicates that influenza virus may exploit endocytic entry routes other than clathrin-
dependent endocytosis, which is utilized by SFV and VSV. Recent studies from the 
Whittaker lab showed that in control to SFV, the infectivity of influenza viruses in cells 
expressing a dominant-negative mutant of Eps15, which inhibits clathrin-dependent 
endocytosis specifically, was not impaired in contrast to SFV (Sieczkarski and Whittaker, 
2002a). Influenza infection is not inhibited by chemical inhibitors of caveolar-mediated 
endocytosis or an inhibitory mutant of caveolin-1 (Sieczkarski and Whittaker, 2002a). 
These observations led to the discovery of a non-clathrin-dependent, non-caveolae-
dependent endocytic pathways for influenza virus entry in addition to classical clathrin-
dependent pathway. 
Thanks to advances in super-resolution fluorescent microscopy, individual 
influenza particles can be tracked in real time without disruption of endocytic pathways. 
The population of influenza particles entering BSC-1 cells via clathrin-dependent 
pathway is approximately 65%; while 35% of virus particles are endocytosed via 
clathrin-independent pathways (Rust et al., 2004). Examining the dynamics of the 
endocytic uptake also leads to the conclusions that influenza viruses exploit different 
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pathways with the same efficiency and that non-classical pathways are not alternative 
pathways for influenza virus entry (Chen and Zhuang, 2008). 
 Recently, by performing a detailed dissection of influenza entry pathways 
independent of dynamin using pharmacological inhibitors, de Vries et al. discovered that 
influenza virus utilizes a macropinocytosis-like route of entry that is independent of 
dynamin in many cell types (de Vries et al., 2011). One speculation for the reason why 
influenza virus uses macropinocytosis as entry pathway is the size of the influenza virus. 
Influenza virus has two morphotypes: spherical virions about 100nm in diameter and 
filamentous virions up to 20um in length. It is not surprising that instead of utilizing 
clathrin-mediated endocytosis route of entry, macropinocytosis is a dominant entry route 
by filamentous influenza virus (Rossman et al., 2012).  
 
1.2.4   Polarized epithelial cells as sites of infection for influenza virus in vivo 
In humans, influenza is transmitted from infected individuals through the air 
within aerosols generated by coughing or sneezing. The main targets of influenza virus 
are the ciliated epithelial cells of the upper respiratory tract, which consist of several cell 
types with distinct functions (Hers, 1966; Jeffery and Li, 1997). Influenza viruses can 
also infect many different cell types of airway epithelial cells in humans and monkeys 
(Rimmelzwaan et al., 2001; Tateno et al., 1966). Intracellular trafficking of influenza 
virus is extensively studied in non-polarized cell systems such as HeLa (cervical cancer 
cells), CHO (Chinese hamster ovary cells), and BSC-1 (African green monkey kidney 
cells) (Chen and Zhuang, 2008; Sieczkarski and Whittaker, 2002b). These molecular 
studies have been carried out using influenza virus infection in non-polarized cell lines 
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and such cells are not the in vivo target of viral infection. 
Polarized, simple epithelial cells have a plasma membrane that is separated by 
tight junctions into two clearly distinct domains. The apical domain faces the tract lumen 
and may contain microvilli, while the basolateral surface faces the extracellular matrix. 
Actin filaments, microtubules, as well as an array of cellular proteins participate in the 
organization and maintenance of cell polarity. Simple epithelial cells have apical and 
basolateral endocytic pathways, each of which uses a complex series of compartments. 
These pathways can lead to recycling or degradation, but also to transcytosis, the 
selective transcellular vesicular transport from one pole of the epithelium to the opposite 
one (Cao et al., 2012). Previous studies have shown that influenza enters and buds from 
the apical domain of MDCK cells (Rodriguez Boulan and Sabatini, 1978). In either virus-
infected cells or cells expressing viral proteins, each viral envelope protein (HA, NA, 
M2) possesses an apical sorting signal and preferentially localizes at the apical domain 
(Hughey et al., 1992; Jones et al., 1985; Roth et al., 1983). Since there are significant 
differences between polarized and non-polarized cells with regards to receptor 
distribution, cytoskeletal structure and the mechanism of endocytosis, it is possible that 
our current knowledge of influenza virus entry does not completely apply to viral 
infection in vivo.  
Although we currently have much information on the entry process of influenza 
virus, there is still limited information on the specific route of entry into polarized 
epithelial cells, which are the target cells of influenza infection in vivo. In culture, MDCK 
cells have proven to be a robust and much studied model of polarized epithelia. MDCK 
cells are often used for studies of influenza virus, but very rarely in detailed studies of 
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virus entry under conditions where polarity is monitored. In general, polarized cells are a 
more difficult experimental system. Care must be taken to maintain a true polarized 
epithelium, and polarized cells are refractory to conventional transfection approaches, 
making the transient transfection dominant-negative methodology problematic.  
 
Summary 
The goal of this thesis work is to better understand the attachment and endocytosis 
of coronavirus and influenza virus entry process. In Chapter 2, the role of DC-SIGN/L-
SIGN as potential attachment factor for IBV was examined. In Chapter 3, different 
virological aspects of IBV infection in chicken peripheral blood derived monocytes were 
studied. Finally, in Chapter 5, entry pathways of influenza virus in polarized epithelial 
cells were investigated. In all, this work substantially added to our understanding of 
mechanisms of virus-host interaction.     
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CHAPTER 2 
 
Expression of the C-type lectins DC-SIGN or L-SIGN alters host cell susceptibility 
for the avian coronavirus, infectious bronchitis virus 
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2.1   Abstract 
Infectious bronchitis virus (IBV), an avian coronavirus, is a cause of great 
economic loss in the poultry industry. The virus mainly infects respiratory epithelium, but 
can be also detected in other organs. The functional receptor for the virus has not been 
found and field strains of IBV do not infect conventional cell lines. Recently, it has been 
shown that the Ctype lectins DC-SIGN/L-SIGN can promote entry of several 
coronaviruses. Here we examine whether DC-SIGN/L-SIGN are entry determinants for 
IBV. We show that by introducing human DC-SIGN/L-SIGN into non-permissive cells, 
infection by the IBV is dramatically increased. DC-SIGN mediated infection was 
inhibited by mannan and antilectin antibodies, and was independent of sialic acid levels 
on the cell. Enhancement of IBV infection also occurred for different serotypes of IBV. 
Our findings demonstrated that even in the absence of avian-specific receptor, DC-SIGN-
like lectins are capable of mediating efficient IBV infection. 
 
2.2   Introduction 
Infectious bronchitis virus is the type species of the family Coronaviridae, and is 
part of the Gammacoronavirus genus (Woo et al., 2009). Within the Coronaviridae, 
individual species are able to infect a wide array of animals, including but not limited to 
humans, dogs, cats, pigs, cows, birds, bats, and whales. IBV mainly infects chickens, and 
globally causes great economic loss for the poultry industry every year (Saif, 2003b). 
Although IBV mainly infects the ciliated epithelia in the respiratory tract of chickens and 
causes respiratory disease, many studies have discovered that IBV can also spread to 
other organs of the chicken and can cause pathology in other issues, such as alimentary 
 37 
tract, testes, oviduct, and Harderian gland (Bezuidenhout et al., 2011; Raj and Jones, 
1997). Clinical signs include coughing, sneezing, nasal discharge, loss of appetite, and 
reduction in egg laying (Saif, 2003). In addition to the original Massachusetts serotype, 
dozens of serotypes and genotypes of IBV have now been detected (Meir et al., 2010). 
Many strains can cause major or minor nephritis in both naturally infected or 
experimentally infected chickens (Lambrechts et al., 1993). 
Susceptibility of virulent strains of IBV to different cell lines has been 
sporadically reported; e.g. chicken fibroblasts (Nazerian and Cunningham, 1968), HeLa 
cells (Chen et al., 2007), primary chicken tracheal epithelial cell (Shen et al., 2010), but 
currently the only way to efficiently propagate IBV is by using embryonated chicken 
eggs. In cell culture, while most field strains of IBV can infect primary chicken derived 
cells (e.g. chick kidney and tracheal cells), no cell lines are generally considered to be 
susceptible to IBV infection. The exception to this is the Beaudette strain, which is a 
highly embryo- and cell-culture adapted non-virulent virus and can infect cell lines 
derived from a variety of mammalian species (Saif, 2003b). 
The ability of IBV to infect different tissues in chickens may be linked to the 
receptor distribution within these tissues. Although the virus was first identified almost 
80 years ago, the primary receptor for IBV has not been identified. There was speculation 
that feline aminopeptidase N (fAPN), which can serve as a common receptor for many 
Alphacoronaviruses, is a receptor for IBV (Miguel et al., 2002). This was based in part on 
the ability of the Ark99 strain of IBV to infect feline kidney cells (Miguel et al., 2002). 
However, these studies were not confirmed with additional isolates of IBV (Chu et al., 
2007) and the current view is that APN is not a functional receptor utilized by IBV. There 
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have also been studies showing that the tissue tropism of IBV may be linked to the use of 
sialic acid as an attachment factor, which is present on cell surface of various tissues 
(Winter et al., 2006). In addition, heparin sulfate has been reported as an attachment 
factor specifically for the Beaudette strain of IBV (Madu et al., 2007). 
Dendritic Cell-Specific Intercellular adhesion molecule-3-Grabbing Non-integrin 
(DC-SIGN) and its closely related Liver/lymph node-specific ICAM-3 grabbing non-
integrin (L-SIGN) are calcium-dependent lectins. DC-SIGN was first discovered to be 
important in human immunodeficiency virus type 1 (HIV-1) pathogenesis (Geijtenbeek et 
al., 2000). This lectin, expressed mainly on dendritic cells, is believed to interact with the 
HIV-1 surface glycoprotein gp120 and enable capturing and transporting of the virus 
particle from mucosal infection site to secondary lymphoid tissues (Geijtenbeek et al., 
2000). DC-SIGN is also able to enhance HIV-1 infection in cis as an attachment factor 
(Lee et al., 2001). With a similar structure to DC-SIGN, L-SIGN is able to capture HIV-1 
in the same manner. Many enveloped viruses such as Ebola virus, hepatitis C virus, and 
Sindbis virus also have been shown to be interacting with DC-SIGN and/or L-SIGN 
presumably via interaction with high-mannose glycoproteins on the viral particles 
(Alvarez et al., 2002; Klimstra et al., 2003; Navarro-Sanchez et al., 2003; Pohlmann et 
al., 2003).  
For coronaviruses, there have been increasing numbers of reports demonstrating a 
role for human DC-SIGN and/or L-SIGN in pathogenesis of SARS coronavirus, human 
coronavirus-229E, human coronavirus-NL63, as well as feline coronavirus by 
enhancement of infection (Hofmann et al., 2006; Marzi et al., 2004; Regan and 
Whittaker, 2008; Yang et al., 2004). Based on the evidence that human DC-SIGN is able 
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to promote infection of non-human viruses, i.e. feline immunodeficiency virus and feline 
coronavirus (de Parseval et al., 2004; Regan and Whittaker, 2008), we were interested in 
whether human DC-SIGN or L-SIGN might be an entry determinant for IBV and whether 
they may function in combination with fAPN.  
In our study, we demonstrate that by introducing DCSIGN or L-SIGN into non-
permissive cells, infection of IBV strain M41 is dramatically increased. This 
enhancement of infection also applies to various field strains of virulent IBVs and is 
independent from the previous reported attachment factor sialic acid. Our findings 
indicate that there may be a role for DC-SIGN for IBV spread from one organ to another, 
but that an additional receptor is involved in the infection of epithelial cell types, which is 
likely to be distinct from APN.  
 
2.3   Materials and Methods 
Virus strains  
IBV strains used in this study were M41, Cal99, Conn46, Iowa609, Gray, Iowa97, 
and JMK. For preparation of virus stocks, approximately 102 EID50 of IBV was 
inoculated into 10-day-old specific-pathogen-free chicken embryos. Allantoic fluid from 
infected embryos was collected 48 h post inoculation, and subjected to clarification by 
centrifugation at 1800 x g for 15 minutes at 4°C. For concentrated IBV-M41 virus 
preparation, the allantoic fluid was further centrifugated at 34500 x g for 60 minutes at 
4°C using a Ti45 rotor (Beckman Coulter). The virus pellet was resuspended in 
phosphate buffered saline (Cellgro). IBV allantoic fluid was titered by egg infectious 
dose 50 assay. IBV concentrated preparation was titered by tissue culture infectious dose 
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50 assay. Influenza virus strain A/WSN/33 was propagated in MDBK cells and 
supernatant was collected 48 h post infection. Influenza virus preparation was titered by 
plaque assay.  
 
Cell culture and plasmids 
3T3-DCSIGN cells were obtained from the NIAID AIDS Research and Reference 
Reagent Program. NIH3T3, CRFK, Vero E6, and BHK-21 cells were purchased from 
ATCC. 3T3-fAPN, CRFK-fAPN, and CRFK-DCSIGN cells were kindly provided by Dr. 
Andrew D. Reagan, Cornell University. 3T3, CRFK, Vero E6, and BHK-21 cells were 
grown in DMEM supplemented with 10% fetal bovine serum and 1% 
Penicillin/Streptomycin (Pen/Strep). The stable cell lines were grown in DMEM 
supplemented with 10% fetal bovine serum, 1% Penicillin/Streptomycin, and 400 µg/ml 
G418. Chicken embryonic kidney cells were purchased from Charles River Laboratories 
and were cultured in basal media (Invitrogen) supplemented with 10% calf serum and 1% 
Pen/Strep. Plasmids of hDC-SIGN and hL-SIGN were obtained from the NIAID AIDS 
Research and Reference Reagent Program. For transfection assays, 250 ng of plasmid 
DNA were mixed with 0.75µl of Lipofectamine 2000 (Invitrogen) in 50 µl of Opti-MEM 
(Gibco) at room temperature according to manufacturer’s protocol. Cells seeded on glass 
cover slips were transfected at 37°C over night before viral infection.  
 
RT-PCR for viral infection detection 
106 3T3 or 3T3-DCSIGN cells were seeded onto 6 well plates and infected with 
different dilutions of allantoic fluid of IBV-M41. Total RNA was extracted from IBV-
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M41 infected 3T3 or 3T3-DCSIGN cells 8 h post infection using a Qiagen RNeasy Mini 
Kit following manufacturer’s protocols. Total RNA was reversed transcribed into cDNA 
by using SuperScript One-Step RT-PCR kit (Invitrogen). Negative-strand RNA was 
reversed transcribed into cDNA using ThermoScript Reverse Transcriptase (Invitrogen) 
with anti-sense primer. PCR reaction with High Fidelity Platinum Taq polymerase 
(Invitrogen) was conducted in a Bio-Rad DNA Engine Peltier Thermal Cycler with 
conditions of 1 cycle of 94°C for 2 minutes, 30 cycles at 94°C for 30 seconds, 48°C for 
30 seconds, 72°C for 1 minute, and 1 cycle of 72°C for 5 minutes. Primers for detecting 
nucleocapsid protein (N) of IBV and host glyceraldehyde 3-phosphate dehydrogenase 
protein (GAPDH) were described by (Shen et al., 2010). 10 µL of the PCR products were 
visualized on a 1% agarose gel.   
 
Virus infection and immunofluorescence assay 
Virus stocks were stored at -80°C, and for infection were diluted in RPMI 1680 
medium containing 0.2% bovine serum albumin (Sigma) and adjusted pH to 6.8 with 
HEPES. Cells were infected for 1 h at 37°C without CO2 on a rocking platform, and then 
were washed 3 times with PBS before incubating in 2% FBS/DMEM/1%Pen/Strep 
incubation medium. For immunofluorescence assay, cells were seeded on glass cover 
slips for 24 h, infected or transfected and fixed with 100% methanol for detection of IBV 
viral antigens or 3% paraformaldehyde for other antigens. For detection of IBV viral 
antigen, the anti-S1 monoclonal antibody 15:88 was used for IBV-M41. The anti-M 
monoclonal antibody 9:19 was used for the panel of IBV isolates. The anti-NP 
monoclonal antibody H10, L16-4R5 was used for influenza infection detection (ATCC). 
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For detection of DC-SIGN, monoclonal antibody 14EG7 (NIAID AIDS Research and 
Reference Reagent Program) was used. The secondary antibodies AlexaFluor goat anti-
mouse 488 or AlexaFluor goat anti-mouse 568 with isotype specificity against primary 
antibodies were purchased from Molecular Probes. Nuclei were stained with Hoechst 
33258 (Molecular Probes). Cover slips with cells were mounted on glass slides using 
Mowiol and were examined on a Nikon Eclipse E600 fluorescence microscope equipped 
with a SensiCam EM (Cooke Corp.). 
 
Treatment with mannan, DC-SIGN specific antibody, neuraminidase or sugars 
Cells were incubated with mannan at a concentration of 50µg/ml (Sigma), 
monoclonal antibody 9E9A8 specific for hDC-SIGN at 20mg/ml (NIAID AIDS Research 
and Reference Reagent Program), neuraminidase, or sugars in DMEM media for 1 h at 
37°C before virus infection.  Both mannose and galactose were purchased from Sigma 
and were used at a concentration of 0.01M.  
 
2.4   Results 
To determine a role for C-type lectins in the entry of IBV into host cells, we 
transiently expressed either DC-SIGN or L-SIGN in cell lines that are known to be 
refractory to infection by clinical strains of IBV, such as M41, and examined these cells 
for virus infection. Figure. 2.1. shows 3T3 (A) or CRFK cells (B) transfected with 
plasmids expressing DC-SIGN or L-SIGN, or with a control plasmid, and then infected 
with IBV M41. Cells expressing DC-SIGN or L-SIGN were identified with anti-lectin 
antibodies. In the absence of lectin expression, we observed no infection with IBV M41.  
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Figure 2.1. IBV-M41 infection of 3T3 and CRFK cells is enhanced by introduction 
of hDC-SIGN or hL-SIGN. 3T3 (A) or CRFK (B) cells were transfected with 
expression plasmids for hDC-SIGN or hL-SIGN and infected with 103TCID50/ml of 
IBV-M41 for 1 h at 37°C. Cells were washed 3 times with sterile PBS and further 
incubated for 12 h before fixing with methanol. Viral S protein was detected by 
immunofluorescence microscopy using the anti-S1 mouse monoclonal antibody 15:88 
following by goat anti-mouse AlexaFluor-568. Lectin expression was detected using the 
14EG7 monoclonal antibody. Cell nuclei were counterstained with Hoechst 33258. 
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However, in the presence of DC-SIGN or L-SIGN expression, there was a strong 
correlation of IBV M41 infection in lectin-expressing cells. Figure. 2.2. shows a 
quantification of the rescue of IBV infection, in this case using 3T3 and CRFK cells lines 
stably expressing DC-SIGN, as well as 3T3 and CRFK cells expressing feline 
aminopeptidase N (fAPN)—which has been previously proposed to be a receptor for 
IBV. Both 3T3 and CRFK cells expressing DC-SIGN were efficiently infected with IBV 
M41, whereas there was no apparent rescue of infection in 3T3 or CRFK cells expressing 
fAPN. Overall, these data strongly suggest that over expression of the C-type lectins L-
SIGN or DC-SIGN can act as part of an IBV receptor complex and allow infection of 
3T3 or CRFK cells that are otherwise resistant to IBV infection, and further support the 
idea that fAPN is not a functional receptor for IBV. 
To further examine the role of C-type lectins for IBV entry, we treated DC-SIGN-
expressing cells with either mannan or anti-DC-SIGN antibodies, and then infected the 
cells with IBV M41. Mannan is a polymer of mannose that is well recognized to compete 
with mannose-containing carbohydrates on glycoproteins and block interactions of 
viruses with C-type lectins. Both mannan and anti-DC-SIGN antibodies inhibited 
infection by IBV M41 (Figure 2.3.), further supporting a specific role for DC-SIGN as 
part of the IBV receptor complex, and indicating that the interactions are mediated 
through mannose-containing carbohydrate residues present on the viral spike protein. In 
addition, infection was inhibited by the Ca2+-sequestering agent  EGTA (data not shown), 
further indicating a specific role for C-type lectins, which are known to be Ca2+-
dependent for their function. 
To confirm that DC-SIGN-mediated entry of IBV M41 into cells allowed 
 46 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2. IBV-M41 infection is enhanced on 3T3 or CRFK cells stably expressing 
DCSIGN. 3T3 or CRFK cells stably expressing DCSIGN cells were infected with 
103TCID50/ml of IBV-M41 for 1 h at 37°C. Cells were washed 3 times with sterile PBS 
and further incubated for 12 h before fixing with methanol. Viral S protein was detected 
by immunofluorescence microscopy using the anti-S1 mouse monoclonal antibody 15:88 
following by goat anti-mouse AlexaFluor-568. Cells were quantified by scoring the 
percentage of cells positive for viral antigen. >200 cells were quantified from three 
independent experiments. Error bars represent the standard deviation from the mean. 
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Figure 2.3. Specificity of enhancement of infection by IBV-M41. 3T3-DCSIGN cells 
were treated with 50µg/ml mannan (A) or 20mg/ml anti-DC-SIGN antibody 9E9A8 (C) 
prior to infection with 103TCID50/ml of IBV-M41. Cells were fixed at 24 h post 
infection and analyzed by immunofluorescence microscopy. Cell nuclei were 
counterstained with Hoechst 33258. For each treatment, cells were quantified by scoring 
the percentage of cells positive for viral antigen (B and D). >200 cells were quantified 
from three independent experiments. Error bars represent the standard deviation from the 
mean. 
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complete genome replication, we extracted total RNA from either 3T3 or 3T3-DC-SIGN 
cells infected with IBV M41 (Figure 2.4.). We then performed RT-PCR to detect the 
presence of both total and negative-sense viral RNA. In 3T3 cells, we could detect a low 
level of total viral RNA, but with no detectable negative-sense viral RNA. This indicates 
that there was some of the original virus inoculum remaining in the sample, but that viral 
replication had not taken place. In contrast, 3T3-DC-SIGN cells showed a strong signal 
for both total and negative-sense viral RNA confirming that DC-SIGN expression can 
rescue replication of IBV M41 in cells that are otherwise refractory to infection. 
Sialic acid has been proposed to be part of the receptor complex for IBV M41 
(Winter et al., 2006), and so we examined whether there may be any interplay between 
sialic acid and C-type lectins for entry of IBV M41 (Figure 2.5.). 3T3-DC-SIGN cells 
were infected with IBV M41 in the presence of varying concentrations of neuraminidase, 
which would cleave sialic acids on the cell surface but not affect C-type lectin function. 
As a control we used influenza virus, which is well established to use sialic acid as a 
functional receptor. As expected, influenza infection was strongly inhibited by 
neuraminidase treatment in a dose-dependent manner. In contrast, there was no overall 
effect of neuraminidase treatment on IBV M41 infection. These data indicate that there is 
no functional interplay between sialic acid and C-type lectins as part of the IBV receptor 
complex, and that C-type lectin-mediated interactions dominate over sialic acid-mediated 
interactions for IBV M41 infection.  
IBV exists in several serotypes, which are antigenically distinct and so may differ 
in their receptor requirements. To determine whether C-type lectins can promote entry of 
a range of different IBVs, we infected 3T3 (not shown) or 3T3-DC-SIGN cells (Figure 
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 Figure. 2.4. Replication of IBV-M41 in 3T3-DC-SIGN cells. 3T3 or 3T3-DCSIGN 
cells were infected with 200µl virus inocula of allantoic fluid dilutions of IBV-M41 with 
titer of 108.3EID50/ml for 1 h at 37°C. 8 h post infection, total RNA was extracted from 
cells and was subjected to RT-PCR with primers targeting to IBV nucleocapsid N gene or 
host GAPDH gene. Anti-sense RNA was used to derive negative strand specific cDNA. 
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Figure 2.5. Effect of neuraminidase treatment on 3T3-DCSIGN cells infected by 
IBV-M41 3T3-DCSIGN cells were pre-treated with neuraminidase and then were 
infected by M41 (103TCID50/ml), or a control virus, influenza A/WSN/33 (MOI of 5). 
At 12 h post infection (M41) or 5 h post infection (WSN), cells were fixed and stained for 
immunofluorescence microscopy with 15:88 anti-S1 mouse monoclonal antibody (M41) 
or anti-NP mouse monoclonal antibody (WSN/33). Cells were quantified by scoring the 
percentage of cells positive for viral antigen. >200 cells were quantified from three 
independent experiments. Error bars represent the standard deviation from the mean.
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Figure 2.6. The 3T3-DCSIGN cell line is susceptible to various IBV strains 
representing the major viral serotypes. 3T3-DCSIGN cells were infected with the 
allantoic fluid of embryonated eggs infected with various IBV isolates for 1h at 37°C. 
Cells were fixed at 24 h post infection and analyzed by immunofluorescence microscopy 
using the 9:19 anti-M antibody. Cell nuclei were counterstained with Hoechst 33258. 
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2.6.) with the IBV strains Cal99, Conn46, Iowa609, Gray, Iowa97 and JMK, which cover 
the major virus serotypes. In all cases we observed efficient infection of 3T3-DC-SIGN 
cells with the IBV strain used, confirming that C-type lectins such as DC-SIGN can 
promote entry of a wide range of distinct IBV strains. 
To examine the role of C-type lectin in IBV infection in vivo, we used primary 
chicken kidney cells, a chicken cell type that is naturally susceptible to IBV infection. 
While we were not able to inhibit the IBV-M41 strain infection in chicken kidney cells 
with mannan at 50 µg/ml concentration (data not shown), we observed notable reduction 
in infection with presence of 0.01M mannose, the sugar monomer enriched in mannan 
(Figure 2.7.). As the control, galactose treatment at the same concentration did not render 
a similar decrease in infection. Our data suggest that there may be a role for a C-type 
mannose-binding lectin during IBV infection of the chicken host.  
   
2.5   Discussion 
Infection of cells and cell lines in culture by field strains of the avian coronavirus 
infectious bronchitis virus (IBV) is typically restricted to primary chicken cells, such as 
chicken kidney (CK) cells. Here we show that two standard cell lines, mouse 3T3 and 
feline CRFK cells can be efficiently infected by the prototype IBV strain M41 when these 
cells lines express the C-type lectins L-SIGN or DC-SIGN. Similar rescue of coronavirus 
infection has also been observed for a range of different coronaviruses, including SARS-
CoV, HCoV-229E and feline coronaviruses (Jeffers et al., 2006; Jeffers et al., 2004; 
Regan and Whittaker, 2008). While it is presently unclear whether L-SIGN and DC-
SIGN act as coronavirus attachment factors or bone fide receptors, it is clear that the use 
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Figure 2.7. Effect of carbohydrates on IBV-M41 infectivity in chicken embryonic 
chicken cells. Chicken embryonic kidney cells were treated with either 0.01M mannose 
or 0.01M galactose before infection with IBV-M41. Cells were fixed at 8 h post infection 
and analyzed by immunofluoresence microscopy and quantified as previous experiments.  
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of a C-type lectin during coronavirus entry can lead to a major shift in host cell tropism. 
In the case of IBV, the data presented here show efficient infection of mouse or feline 
cells, and we expect that infection would not be limited to these cells, but would occur in 
many cell types. It is possible the utilization of a C-type lectin may be involved in host 
range changes that are known to occur with coronavirus infections. Alternatively, use of 
L-SIGN and DC-SIGN may be involved in the spread of the virus to new cell types or 
target organs within an infected animal. Although it is evident that IBV viral replication 
took place in the mouse cell line expressing DC-SIGN, the level of released viruses into 
the infected cell culture supernatant was not observed, possibly due to defects in virus 
assembly or release in these mouse cells (data not shown). 
Our studies rely on the use of a human lectin to rescue IBV infection. A chicken 
holmolog of L-SIGN and DC-SIGN has not been identified and so it remains unclear 
what lectins might be involved in IBV infection in the chicken. We performed BLAST 
analysis of the chicken genome in an attempt to reveal potential chicken homologs of 
DC-SIGN. Three lectins, chicken hepatic lectin, the chicken C-type lectin receptor B-NK 
and chicken B-lec, were identified as the closest homologs to human DC-SIGN by amino 
acid sequence. Each of these homologs was cloned and expressed in 3T3 cells, but in 
each case the expressed lectin was unable to rescue infection of IBV (data not shown). 
The failure to rescue IBV infection may be due to differences in carbohydrate specificity. 
It is thought that DC-SIGN binds to high mannose and/or fucose residues on the 
glycoproteins (Guo et al., 2004) including the coronavirus spike protein (Khoo et al., 
2008) and the potential chicken DC-SIGN homologs tested may have different 
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carbohydrate-binding specificity. For example, chicken hepatic lectin, which has the 
highest homology to human DC-SIGN, is known to be specific for terminal N-
acetylglucosamine on glycoproteins (Kawasaki and Ashwell, 1977). Thus a functional 
equivalent to DC-SIGN remains to be identified in the chicken. 
Previous reports have indicated a low level of IBV infection in feline CRFK cells, 
suggesting that feline APN (fAPN) is a possible IBV receptor. While feline CRFK cells 
were rescued for IBV infection by DC-SIGN expression, the same situation occurred for 
mouse 3T3 cells. Assuming that DC-SIGN is acting in concert with an additional IBV 
receptor, it appears that both mouse and feline homologs of this receptor are able to act, 
at least in the presence of high levels of DC-SIGN expression. In addition to testing for 
the function of over-expressed fAPN, we also cloned and expressed the chicken 
aminopeptidase N (chAPN). However, like fAPN, this potential receptor failed to rescue 
infection by IBV (data not shown). Cell lines in culture typically do not express C-type 
lectins such as DC-SIGN. However we observed that there was is always a very low 
amount of infection observed in most avian and mammalian cell lines tested, perhaps due 
to a very low level of C-type lectin expression or the inefficient use of a homologous 
(non-chicken) receptor.  
While C-type lectins can allow infection of cells by IBV, they are unlikely to be 
the sole component of the IBV receptor complex in chicken epithelial cells, since we 
were not able to find a critical role of mannose-binding molecules in the infection of 
chicken kidney cells by IBV. While in vivo infection with most IBV strains is primarily 
localized to the respiratory tract, it is known that certain strains can spread to other 
organs, e.g. kidney and oviduct. This in vivo spread is likely to be highly influenced by 
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C-type lectin expression and distribution, especially in relation to the proposed role of 
hematopoetic cells, such as macrophages, which often express high levels of C-type 
lectins and can readily disseminate the virus to distant organs. Nevertheless, the C-type 
lectin molecules DC-/L-SIGN are able to mediate efficient IBV infection even in the 
absence of a chicken—specific receptor. Overall, our findings on lectin–virus interactions 
reveal important parts of the IBV receptor complex, the full intricacy of which remains to 
be determined.  
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CHAPTER 3 
 
Productive infection of avian coronavirus infectious bronchitis virus in chicken 
peripheral blood-derived monocytes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yueting Zhang and Gary R. Whittaker 
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3.1   Abstract 
The Coronavirus family comprises a variety of single-stranded RNA, enveloped 
viruses that infect a wide range of animal species, and the prototype avian coronavirus 
infectious bronchitis virus (IBV) is a continuing economic concern for the poultry 
industry. IBV typically infects the respiratory tract, but can also spread to and cause 
pathology in numerous other organs, including the kidney, gastrointestinal tract and the 
oviduct/testis. The current method of control for IBV is by vaccination, and the humoral 
response of IBV infection in chickens has been extensively studied. Although studies 
have shown that host innate immune responses to IBV contribute to the development of 
infectious bronchitis, little is known about the role of antigen-presenting cells for IBV 
immunopathogenesis. In our study, we utilized peripheral blood-derived 
monocytes/macrophages from chickens (chPBMC) and show that these cells are 
productively infected by clinical strains of IBV, such as M41. We show that IBV M41 
induces apoptosis in chPBMCs within 6h post-infection, which does not require viral 
replication, and that chPBMCS are infected by a low pH-dependent, dynamin-
independent pathway. Our data also show that sialic acid is dispensable for IBV M41 
infection of chPBMCs, and that C-type lectins may function as co-receptors/attachment 
factors in chPBMCs. In conclusion, our data suggest that infection of chPBMCs may play 
a role in the IBV-mediated innate immune response, and play an important role for viral 
pathogenesis in chickens. 
3.2   Introduction 
Infectious bronchitis virus is an avian coronavirus that infects chickens, and is the 
prototype member of the Gammacoronavirus genus (Hudson and Beaudette, 1932; Woo 
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et al., 2009). Despite extensive vaccination, IBV poses continuous economic threat to the 
poultry industry globally. The primary site of infection for IBV is the epithelial cells of 
the respiratory tract; however IBV can spread to other organs of the host, with known 
susceptible organs that include the gastrointestinal tract, the kidneys, the reproductive 
tract/organs and the Haderian glands (Bezuidenhout et al., 2011; Raj and Jones, 1997). 
Viremia has generally been suggested as the way for internal spread of IBV, as evidenced 
by detection of virus in the blood of infected chickens (Chen et al., 2010a; Hofstad and 
Yoder, 1966). However, the exact mechanism of internal spread of IBV remains 
unknown. Other coronaviruses, such as SARS-coronavirus (SARS-CoV) (Ding et al., 
2003), and feline coronavirus (FCoV) (Rottier, 1999), exhibit well recognized systemic 
infection. In these cases, monocytes, macrophages, and dendritic cells (DCs), originating 
from a common myeloid progenitor, act to disseminate the virus and also act as an 
important immunopathogenic component in disease development (Perlman and 
Dandekar, 2005). For instance, SARS-CoV has an abortive infection in human 
macrophages or DCs, but is capable of inducing pro-inflammatory cytokines in these 
cells (Frieman and Baric, 2008). Likewise, feline macrophages can be productively 
infected by FCoV and can be utilized by FCoV to disseminate to various organs, with 
macrophage activation leading to the production of pro-inflammatory cytokines critical to 
pathogenesis (Kipar et al., 2010).  
In the case of IBV, previous studies have shown that chicken bone marrow-
derived macrophages were resistant to infection in vitro (von Bulow and Klasen, 1983). 
However, macrophages from different anatomical sites of a host can elicit distinct 
functions or responses to foreign pathogens (Murray and Wynn, 2011; Perlman and 
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Dandekar, 2005). To explain the known presence of IBV in the blood of infected 
chickens (Chen et al., 2010a; Hofstad and Yoder, 1966), we reasoned that peripheral 
blood-derived monocytes/macrophages from chickens (chPBMCs) could be susceptible 
to IBV infection.  Here we show that chPBMCs are highly susceptible to IBV infection in 
vitro, with rapid induction of apoptosis in these cells, suggesting that infection of 
chPBMCs plays a role in the IBV-mediated innate immune response, and has an 
important role for viral pathogenesis in chickens. 
 
3.3   Materials and methods 
Virus preparation 
IBV strains used in this study were M41, Cal99, Conn46, and Iowa97. For preparation of 
virus stocks for infection, approximately 102 EID50 of IBV was inoculated into 10-day-
old specific-pathogen-free chicken embryos. At 48 h post inoculation, allantoic fluid 
from infected embryos was collected and clarified by centrifugation at 1800 x g for 15 
minutes at 4°C. To further concentrate IBV-M41, the allantoic fluid was 
ultracentrifugated at 34500 x g for 60 minutes at 4°C using a Ti45 rotor (Beckman 
Coulter). The virus pellet was resuspended in phosphate buffered saline (PBS) (Cellgro). 
The virus stocks were stored at -80°C. IBV preparations were titered by egg infectious 
dose 50 (EID50) assay. Concentrated IBV-M41 preparations were titered by tissue 
culture infectious dose 50 (TCID50) assay 
Cell culture 
Chicken peripheral blood monocytes were prepared as described (20). Briefly, fresh 
blood was obtained by cardiac puncture from 6-8 week-old specific-pathogen-free White 
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Leghorn chickens maintained by the Department of Microbiology and Immunology, 
Cornell University. All work with chickens was carried out according to the Cornell 
University Animal Care and Use program and complied with the Public Health Service 
Policy on Humane Care and Use of Laboratory Animals. Monocytes were isolated by 
Ficoll gradient (GE) and were cultured in RPMI 1640 supplemented with 10% heat 
inactivated chicken serum and 1% Penicillin/Streptomycin (Cellgro). 24 h after cell 
seeding, non-adherent or dead cells were washed away with Dulbecco’s PBS (Cellgro) 
and PBS was replaced with fresh culture media. Monocytes for each independent 
experiment were obtained from an individual blood donor. 
Virus infection  
Virus stocks were diluted in RPMI 1640 medium containing 0.2% bovine serum albumin 
(Sigma), 1mM HEPES, pH 6.8. Cells were infected for 1 h at 37°C without CO2 on a 
rocking platform and then were washed 3 times with PBS before incubating in culture 
medium.  
Immunofluorescence assay 
Cells were seeded on glass cover slips. After infection and incubation, cells were fixed 
with 100% methanol for detection of IBV viral antigens, otherwise, cells were fixed with 
3% paraformaldehyde (PFA).  For detection of IBV viral antigen, the anti-S1 monoclonal 
antibody 15:88 was used for IBV-M41. The anti-M monoclonal antibody 9:19 was used 
for IBV-Cal99, IBV-Conn46, and IBV-Iowa97. Monoclonal antibody KUL01 was 
purchased from Abcam. The secondary antibodies AlexaFluor goat anti-mouse 488 
purchased from Molecular Probes. Nuclei were stained with Hoechst 33258 (Molecular 
Probes). Cover slips with cells were mounted on glass slides using Mowiol and were 
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examined on a Nikon Eclipse E600 fluorescence microscope equipped with a SensiCam 
EM (Cooke Corp). Cells were quantified by scoring the percentage of cells positive for 
viral antigen compared to the total number of cells. >200 cells were quantified from three 
independent experiments.  
RT-PCR for viral detection 
106 PBMCs were seeded onto 6 cm dishes and infected with 7x 102 TCID50 of IBV-M41. 
At indicated time points, culture supernatant was collected and was filtered through a 
0.22 µm filter (Corning). Viral RNA was extracted from 140 µl of the supernatant with 
Qiagen Viral RNA extraction kit. RT-PCR reaction was conducted with SuperScript One-
Step RT-PCR kit (Invitrogen) in a Bio-Rad DNA Engine Peltier Thermal Cycler using 
the following PCR cycles: 1 cycle of 94°C for 2 minutes, 30 cycles at 94°C for 30 
seconds, 48°C for 30 seconds, 72°C for 1 minute, and 1 cycle of 72°C for 5 minutes. IBV 
N gene primers were previously described by (17). 
Neuraminidase and lectin treatment  
PBMCs were fixed with 3 % PFA before incubating with 5 µg/mL biotinylated Maackia 
Amurensis (MAA) I, 5 µg/mL Maackia Amurensis (MAA) II, or 1 µg/mL Sambucus 
Nigra Lectin (SNA). Lectins were purchased from Vector Labs. Streptavidin conjugated 
with AlexaFluor 488 was used to visualize the bound lectin on the cells by fluorescence 
microscopy. The lectins described above were incubated with chPBMCs were present 
before infection with IBV, during viral adsorption, and during incubation. Neuraminidase 
(Sigma-Aldrich) was pre-incubated at the indicated concentrations in RPMI media for 1 h 
at 37°C, and was removed by washing the cells three times with PBS before infection 
with IBV. 
 68 
Treatment with carbohydrates and endocytic inhibitors 
 Cells were incubated with carbohydrates (Sigma-Aldrich) or endocytic inhibitors 
(Sigma-Aldrich) in RPMI 1640 media for 1 h at 37°C before infection, for 1 h during 
viral adsorption, as well as for the incubation periods. Treatment with EGTA 
(Calbiochem) was the same except that EGTA was removed 2 h after infection due to its 
toxicity. Post treatments were following the same viral infection protocol and drugs were 
added after viral adsorption.  
Transferrin (Tfn) uptake assay 
PBMCs were seeded on glass clover slips. Prior to performing the uptake assay, cells 
were serum starved for 30 min. 50 µg/ml Tfn conjugated with AlexaFluor 568 
(Molecular Probes) was added to cells in RPMI 1640 for 20 minutes on ice for binding. 
Cells were washed with RPMI and then warmed to 37°C for 15 minutes. Tfn on cell 
surface was washed off with acidic buffer (0.1M NaCl and 0.1M glycine, pH 3). Cells 
were then fixed with 3% PFA for microscopy. 
Apoptosis assays 
PBMCs were infected with 2x103 TCID50 IBV-M41 and at 6 h post infection, reagents 
from a Green FLICA caspase 3/7 assay kit (ImmunoChemistry Technologies) were added 
using the manufacturer’s instructions. Apoptotic cells were visualized by fluorescence 
microscopy. For the DNA laddering assay, total cellular DNA was extracted from 
infected or uninfected PBMCs plated in 6-cm culture dishes using a Qiagen DNeasy 
Blood & Tissue kit at 24 h post infection, and laddering was visualized on 2% agarose 
gel. To inactivate IBV-M41, viruses were placed on ice for 30 minutes under a UV-lamp 
with a wavelength of 254nm. Inactivation was confirmed by loss of infectivity in 
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chPBMCs. Ammonium chloride (NH4Cl) was added to PBMCs before viral infection and 
was present during viral adsorption and incubation. 
 
3.4   Results 
Peripheral blood-derived monocytes from chickens can be productively infected by 
IBV 
To investigate a role for myeloid cells in IBV dissemination and viral 
pathogenesis, we isolated peripheral blood-derived monocytes from chickens (chPBMCs) 
and confirmed that they were positive for the monocyte/macrophage marker KUL01 
(Figure 3.1A). Due to the lack of available reagents for avian species, we were unable to 
further distinguish whether these chPBMCs were matured or differentiated into 
macrophages or dendritic cells, or to determine the composition of unique cell 
populations with specific cell surface antigens. In contrast to previous studies that 
showed bone-marrow-derived macrophages were resistant to IBV infection in vitro (von 
Bulow and Klasen, 1983), we found that chPBMCs are highly susceptible to the IBV 
field strains M41, Cal99, Conn46, and Iowa 97 (Figure 3.1B).  
To examine whether the stage of maturation or differentiation of the adherent 
chPBMCs had an effect on the ability of IBV to infect these cells, we tested the infection 
of chPBMCs at different days post-seeding. Infectivity with IBV- M41 was determined 
using an immunofluorescence assay (Figure 3.1C). The percentage of infected cells 
increased with time, reaching a maximum infectivity of 35% at day 5. However, beyond 
day 3 to 4  
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Figure 3.1. Chicken PBMCs can be productively infected by field strains of IBV 
(A) ChPBMCs (3-day-old culture) were stained with mouse anti-KUL01 avian 
macrophage/monocyte marker antibody; followed by incubation with secondary antibody 
goat anti-mouse AlexaFluor-488. (B) ChPBMCs were infected with IBV-M41, IBV-
Cal99, IBVConn46, or IBV-Iowa97 for 1 h at 37°C. Cells were washed with PBS and 
further incubated for 9 h for IBV-M41 and 23 h for other IBVs. Viral spike protein 
antigen was detected by immunofluorescence microscopy using anti-M41 –specific S1 
mouse monoclonal antibody 15:88 followed by goat anti-mouse AlexaFluor-488. 
Infection of other virus strains was detected with the mouse anti-M protein monoclonal 
antibody 9:19 followed by goat anti-mouse AlexaFluor-488. (C) Infectivity of IBV-M41 
in day 0 to 5 cultures of chPBMCs were determined by immunofluorescence microscopy. 
For each day of culture, monocytes were infected with IBV-M41. Cells were quantified 
by scoring the percentage of cells positive for viral antigen S or M. >200 cells were 
quantified from each of three independent experiments. (D) Filtered supernatants were 
harvested from IBV-M41 infected chPBMC at indicated time points. RT-PCR against 
IBV N gene was performed and amplified DNA products were visualized on an agarose 
gel. The infectious titer of the supernatants containing IBV particles was also determined 
in 10-day-old embryonated eggs by EID50 assay. 
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post-seeding, we observed a large proportion of giant multinucleated cells, as observed 
by previous investigators (Weiss and Fawcett, 1953). In all further experiments, we 
utilized day 3 or day 4 cultures due to difficulty in imaging and quantifying the giant 
cells.  
We next determined whether IBV infection of the chPBMCs produces progeny 
viral particles. RT-PCR was performed to detect the IBV N gene of the released particles 
in the supernatant of infected PBMCs. Starting at 8 h post-infection, we could detect the 
viral RNA in the infected culture, reaching a maximum RNA level at 24 h post-infection. 
To determine whether these progeny virions were infectious, we performed an EID50 
assay on the supernatant samples. The peak viral titer was 108 EID50/mL at 12 h post-
infection. At 24 h post-infection, the viral titer decreased slightly even though RT-PCR 
indicated more virus particles present at this time point (Figure 3.1D). The reduced 
infectivity may be due to aggregation of viral particle between 12 and 24 h post infection.  
IBV induces rapid apoptosis in chPMBCs 
It is known that the IBV Beaudette strain, which is a highly laboratory-adapted 
virus, can induce caspase-dependent apoptosis in Vero cells at 16 h post-infection (Liu et 
al., 2001). To determine whether IBV can induce apoptosis in chPBMCs, we examined 
the activation of caspase 3/7 after infection by IBV-M41 and IBV-Cal99 virus, using a 
FLICA assay, which employs the caspase 3/7 inhibitor FAM-DEVD-FMK that binds to 
activated caspase 3/7 irreversibly. At 6 h post-infection, there was an increase in the 
fluorescence signal in the IBV-infected cells, compared to mock-infected cells, 
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suggesting activation of caspase 3/7 in these cells. Interestingly, upon addition of UV-
inactivated IBV-M41 (2x103 TCID50), chPBMCs also displayed an increase in 
fluorescence signal, indicating that replication-defective IBV is also able to trigger 
apoptosis (Figure 3.2A). To further confirm the IBV-induced apoptosis, cellular DNA 
from mock infected or infected chPBMCs were collected after 24 h post-infection and 
analyzed by agarose gel electrophoresis. DNA from infected cells was fragmented and 
displayed an apoptosis-characteristic laddering, while no obvious laddering was observed 
for mock-infected cells.  
When we added a small amount (5x102 TCID50) of UV-inactivated IBV-M41 was 
added to chPBMCs, such that the same quantity of inactivated particles were used 
compared to infectious IBV M41 particles, DNA fragmentation was no longer observed. 
Since the quantity of defective particles per cell was approximately 200-fold less than the 
quantity used in the experiment in Figure 3.2A, the DNA fragmentation was not able to 
be visualized from such a small population of apoptotic cells.  While some viruses such 
as HIV are able to induce bystander cell death in uninfected CD4+ T cells(Holm et al., 
2004), our data implied that the IBV-induced apoptosis observed in chPBMCs was not 
due to the bystander effect (Figure 3.2B). Our data imply that even though chPBMCs 
could undergo apoptosis by encountering a defective IBV virus, neighboring uninfected 
chPBMCs would not be affected. 
IBV entry occurs via endosomes, in a low-pH dependent manner (Chu et al., 
2006a). To examine whether IBV-induced cell death requires endosomal fusion, we 
treated the chPBMCs with NH4Cl, a cell permeable weak base, to raise the pH in the 
endosomes before infecting with IBV-M41. Presumably IBV particles were arrested in  
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Figure 3.2. IBV-M41 induces rapid apoptosis in chPBMCs (A) Mock infected, live 
IBV-M41, or inactivated IBV-M41 infected chPBMCs were assayed at 6 h post infection. 
Apoptosis was revealed by green fluorescence FLICA caspase 3/7 detection assay. (B) 
Mock infected, IBV-M41(5x102 TCID50) infected, or UV- inactivated IBV-M41(5x102 
TCID50) infected chPBMCs seeded on 6 cm tissue culture dishes were harvested and 
total cellular DNA were extracted at 24 h post infection and analyzed on agarose gel. (C) 
chPBMCs were mock infected, IBV-M41 infected before nuclei were stained with 
Hoechst at 10 h post infection. Apoptotic nuclei were visualized by fluorescence 
microscopy. (D) chPBMCs were treated with different concentrations of NH4Cl before 
adding IBV-M41. At 10 h post infection, apoptotic nuclei were stained with Hoechst and 
visualized by fluorescence microscopy. 
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the endosomes after NH4Cl treatment. Nuclear staining with DNA binding dye Hoechst 
showed that pre-treatment with NH4Cl prevents the condensation of the chromosomes 
(Figure 3.2D). In contrast, non-treated cells and cells treated with NH4Cl after infection 
display fragmentation of the nuclei (Figure 3.2C). These data indicate that IBV-triggered 
apoptosis may require endosomal fusion.  
IBV infection in chPBMCs does not depend on the level of cell surface sialic acid   
It has been previously shown that IBV infection of epithelial cells is dependent on 
cell surface sialic acid. However, avian species are known to have different levels of 
sialic acid at the surface of various tissues such as trachea, kidney, intestine (Ito et al., 
2000; Wickramasinghe et al., 2011). Therefore, we first investigated the sialic acid 
linkages present on our isolated chPBMCs. Biotinylated sialic-acid specific lectins from 
plants: Maackia amurensis lectin I, II and Sambucus nigra lectin have been used to 
distinguish between α2,3 sialic acid linkages (MAA I, II) and α2,6 sialic acid linkages 
(SNA). We found a clear, strong binding of MAA I to chPBMCs, while MAA II binding 
was minimal (Figure 3. 3A). The different binding patterns from these two isoforms of 
MAAs may be due to the specificity of the two lectins: MAA I recognizes the SAα2,3 
Gal β1, 4 GlcNAc sugar moiety while MAA II recognizes SAα2,3 Gal β1, 3GalNAc 
(Geisler and Jarvis, 2011; Nicholls et al., 2007).  Surprisingly, we also observed some 
binding of SNA to the chPBMCs, indicating the possibility that chPBMCs surface 
glycoproteins or glycolipids contain α2, 6-linked sialic acid. The signal of MAAI, MAA 
II, and SNA binding was reduced in a dose-dependent manner upon treatment with 
neuraminidase, which cleaves terminal sialic acids from cell surface glycoproteins  
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Figure  3.3. IBV-M41 infection in chPBMCs does not depend on cell surface the 
sialic acid levels (A) chPBMCs were stained with biotinylated MAA I, MAA II, or SNA 
lectins and sialic acid level was visualized by fluorescence microscopy. (B) Staining of 
sialic acid specific lectins (MAAI, MAAII, and SNA) on chPBMCs treated with different 
concentrations of neuraminidase. (C) chPBMCs were pre-treated with neuraminidase and 
then were infected by IBV-M41. Post-treatment with neuraminidase occurred 1 h post 
infection by IBV-M41. At 10 h post infection (M41), cells were fixed and stained for 
immunofluorescence microscopy with anti-S1 mouse monoclonal antibody. >200 cells 
from each of three independent experiments were scored by positive viral antigens. Error 
bars represent the standard deviation from the mean. (D) chPBMCs were pre-treated with 
sialic acid specific lectins (MAA I, MAA II, SNA) before infection with IBV-M41. Viral 
spike protein antigen was visualized by immunofluorescence microscopy
 78 
 
 79 
 
(Figure 3.3B). To investigate the role of cell surface sialic acid for IBV infection of 
chPMBCs, we treated cells with various concentrations of neuraminidase before infecting 
with IBV. Surprisingly, we did not find a significant reduction in the infection level of 
IBV-M41 in the neuraminidase-treated cells (Figure 3.3C). The slight decrease on the 
infectivity of IBV at 50mU neuraminidase post-infection may be due to the toxicity of 
sialidiase as the neuraminidase post-infection treatment displayed a similar reduction of 
infectivity. When we used the same concentrations of neuraminidase on chicken 
embryonic kidney cells prior to IBV-M41 infection, we confirmed a decrease in IBV 
infectivity, as previously described in the literature (Winter et al., 2006).  To further 
confirm our findings, we also used biotinylated lectins as sialic acid-binding competitors 
for IBV-M41 infection of chPBMCs. Upon pre-treatment with these lectins, we did not 
observe a decrease in IBV-M41 infectivity (Figure 3.3D). Overall, our data indicate that 
sialic acids on the surface of chPBMCs do not play a role in IBV infection. 
 
Inhibition of IBV infection in chPBMCs by EGTA and purified monosacchrides 
Myeloid-origin cells such as monocytes, macrophages, and dendritic cells are 
critical for pathogenesis of numerous coronaviruses, which have been shown to be able to 
utilize C-type lectins such as DC-SIGN or L-SIGN as receptors or attachment factors 
(Hofmann et al., 2006; Marzi et al., 2004; Regan and Whittaker, 2008; Yang et al., 2004). 
Our previous studies determined that human DC-SIGN, when expressed in non-
permissive mammalian cell lines, allows for IBV infectivity (Zhang et al., 2012). To 
investigate whether C-type lectins in chPBMCs can play a role in IBV infection, we 
utilized the calcium-chelating agent EGTA. As C-type lectins require calcium for  
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Figure 3.4. IBV-M41 infection in chPBMCs is sensitive to calcium chelating agent 
EGTA but is insensitive to treatment with a panel of carbohydrates.  (A) chPBMCs 
were pre-treated with EGTA at 2 mM or 5 mM concentrations before (pre-treatment) or 
after (post-treatment) infection by IBV-M41. The bar graph represents quantification of 
immunofluoresence microscopy from three independent experiments. Cells were scored 
for positive viral spike antigen. Error bars represent the standard deviation from the mean. 
(B) Mannan at indicated concentrations was added to chPBMCs prior to IBV-M41 
infection. (C) Carbohydrates at indicated concentrations were added to chPBMC culture 
before infection by IBV-M41. 
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binding, EGTA acts as a general inhibitor of C-type lectins. We observed that IBV-M41 
infection of chPBMC decreased by 80% at 5 mM concentration of EGTA (Figure 3.4A). 
EGTA treatment after IBV infection on the cells did not yield a significant decrease in 
infectivity, suggesting that the reduction of IBV infection occurs during IBV entry and is 
mediated via interactions with C-type lectins. However, we cannot rule out the possibility 
that other cellular components that are critical for IBV infection also require calcium 
ions.  
Next, we treated the chPBMCs with a panel of purified monosaccharides or 
oligosaccharides to investigate whether IBV infection requires a particular sugar moiety. 
Our experiments show that we were unable to inhibit the IBV-M41 infection with 
mannan, mannose, galactose, N-acetyl-galactosamine, or N-acetyl-glucosamine (Figure 
3. 4B and 3.4C).  While not providing support for IBV interaction with C-type lectin, it is 
very possible that there is a specific avian species of carbohydrates that interacts with 
IBV, which remains unidentified and so could not been tested. 
Entry mechanism by IBV-M41 into chPBMC 
Coronaviruses usually enter host cells via receptor-mediated endocytosis and 
require low pH to fuse the viral membrane with host endosomal membrane. For instance, 
SARS-coronavirus is believed to enter cells via a clathrin- and caveolae- independent 
endocytic route (Wang et al., 2008). Our laboratory has previously reported that IBV 
enters cells via endocytosis and requires low pH-dependent fusion activation of the spike 
protein (Chu et al., 2006a; Chu et al., 2006b). To examine the entry route that IBV-M41 
uses to enter the chPBMCs, we used dynasore, a specific inhibitor of the GTPase activity 
of dynamin. Dynamin is a small GTPase that plays an important role in pinching off both 
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clathrin- and caveolae-mediated endocytic vesicles. We pre-incubated chPBMCs with 
various concentrations of dynasore prior to infection with IBV-M41. Infection of the cells 
was scored by the positive fluorescence signal of viral spike protein. Our data revealed 
that there was no significant difference of the percentage of infected cells between the 
various concentrations of dynasore treatment. When we pre-treated chPBMCs with a 
hypotonic solution of sucrose, which inhibits clathrin-coated pit formation in the cell 
membrane, there was also no significant reduction on the percentage of infected cells. As 
a control for the experiments, NH4Cl, a cell permeable weak base commonly used to raise 
the endosomal pH, was added to the chPBMCs before or after virus adsorption. In 
agreement with previous literature, our result confirmed that IBV-M41 is sensitive to pre-
treatment of NH4Cl and IBV enters chPBMCs via a low pH-dependent route (Chu et al., 
2006a) (Figure 3.5A). As a control, both the dynasore and the hypotonic sucrose 
treatment effect were confirmed by the blocking uptake of fluorescent transferrin (Tfn), a 
well-characterized endocytosis marker (Figure 3.5B). We also used another 
pharmacological inhibitor, chlorpromazine (CPZ), which prevents proper clathrin lattice 
assembly, to examine the role of clathrin-mediated endocytosis. However, CPZ was 
found to be toxic to the chPBMC, and therefore, could not be used to elicit the desired 
inhibition of the endocytosis (data not shown). Our data demonstrate that IBV-M41 
utilizes a non-clathrin mediated, dynamin-independent, low pH-dependent entry route 
into chPBMCs. 
Many viruses hijacked caveolaes as internalization pathway. We next examined 
the role of caveolae-dependent endocytosis by treating the chPBMCs with caveolar-
inhibiting drugs during IBV infection. Both MBCD and nystatin bind and  
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Figure 3.5. IBV-M41 entry in chPBMCs is independent of clathrin-mediated 
endocytosis but requires low-pH. (A) ChPBMCs were treated with indicated 
concentrations of dynasore, hypotonic solution or NH4Cl before infection by IBVM41. 
Cells were further incubated for 9 h before fixing for immunofluoresence microscopy. 
Post-treatment with drugs was performed 1 h post infection. (B) chPBMCs were pre-
treated with dynasore or hypotonic solution. AlexaFluor 568-conjugated 
transferrin was bound to cells on ice for 30 minutes. Cells were allowed to warm up to 
37C for transferrin uptake for 10 minutes. Cells were washed with acidic buffer 3 times 
and then fixed with 3% PFA. Nuclei were stained with Hoechst. Transferrin 
uptake was evaluated by fluorescence microscopy. 
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sequester cholesterol and prevents formation of caveolae. Immunofluorescence 
microscopy analysis revealed that the percentage of IBV infected cells reduced by 
increasing concentrations of MBCD treatment or nystatin treatment while the percentage 
of IBV infected cell in post-treatment with drug was comparable to mock treatment 
(Figure 3.6A, 3.6B). This reduction of infection rate indicates that cholesterol plays an 
important role in the IBV infection and IBV utilizes a caveolae-dependent endocytosis 
route in chPBMCs. Monocytes are important antigen-presenting cells in the immune 
surveillance. They constantly internalize foreign antigens by macropinocytosis, an actin-
dependent cellular process. To examine whether macropinocytosis can be utilized by IBV 
to gain entry in chPBMCs, we treated the cells with EIPA, a macropinocytosis inhibitor 
that Inhibits Na+/H+ exchanger activity, during IBV infection. At 50uM concentration of 
EIPA treatment, the percentage of cells was reduced to 50% of percentage of infected 
cells of mock treatment (Figure 3.6C). To confirm the usage of caveolae-dependent 
pathway and macropinocytosis, which are actin-dependent pathways, cytochalasin D, an 
actin polymerization inhibitor, was used to treat the cells during IBV infection. The 
percentage of IBV-infected cells reduced to approximately 50% at the highest 
concentration of cytochalasin D used in our study (Figure 3.6D). In addition, we observed 
that cells treated with MBCD, nystatin, EIPA and cytochalasin D after infection of IBV 
had a higher percentage of infection comparing to mock treatment. The apparent 
increased infectivity may be due to induction of paralleled endocytic pathways. Like 
many other viruses, IBV does not enter host cells in multiple endocytici pathways.   
Taken together, our data suggest that IBV does not enter chPBMCs through classical 
clathrin-mediated endocytosis but utilizes caveolae-mediated  
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Figure 3.6. IBV-M41 entry in chPBMC requires cholesterol and by 
macropinocytosis. ChPBMCs were treated with indicated concentrations of methy-beta-
cyclodextrin (A), nystatin (B), EIPA (C), or Cytochalasin D (D) before infection by 
IBVM41. Cells were further incubated for 9 h before fixing for immunofluoresence 
microscopy. Post-treatment with drugs was performed 1 h post infection. The bar graphs 
represent quantification of immunofluorescence microscopy images from three 
independent experiments. 
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endocytosis as well as macropinocytosis as a way to enter chPBMCs. 
 
3.5   Discussion 
IBV mainly replicates in the epithelial cells of the respiratory tract, but also in the 
epithelial cells of other organs such as kidneys, oviducts and alimentary tract, as 
evidenced by immunohistochemistry of tissue sections from infected chickens (Dolz et al., 
2011). Yet little information on IBV replication in different tissues and cell types is 
available. Our study demonstrates that IBV is able to replicate to high titer (108 EID50/mL) 
in chicken peripheral blood-derived monocytes/macrophages (chPMBCs), cells that are 
imperative for immune surveillance and play a key role in the immune response to viral 
infection. It is known that monocytes originate from the bone-marrow, and then circulate 
in the blood before differentiating into macrophages, dendritic cells, or osteoclasts 
(Gordon and Taylor, 2005). The chPBMCs population that we used in this study 
represents the precursors for macrophages and dendritic cells, and may have 
heterogeneous immunological functions and various levels of susceptibility to IBV. Our 
data show that infection of IBV in chPBMCs follows typical viral growth kinetics, with 
fast growth of the virus, peaks at approximately 12 hr post infection, eventually causing 
cytopathic effect as observed for IBV in other cell types such as chicken kidney cells 
(Saif, 2003a).  
IBV field strains such as Massachusetts 41 (M41), California 99 (Cal99), 
Connecticut 46 (Conn 46) are usually cultivated in chicken embryos, while primary 
chicken kidney cells remain the only option for virus infection and propagation in cell 
culture. No established cell lines allow propagation of clinical strains of IBV (Saif, 
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2003a).  The lack of knowledge in IBV receptor leaves a big gap in our understanding of 
the relatively wide chicken tissue tropism and strict species tropism of IBV. However the 
broad tissue tropism of IBV in vivo has been suggested to be related to the distribution of 
the attachment factor sialic acid (Wickramasinghe et al., 2011), especially in the case of 
the infection of the epithelium of various organs. However, we show here that infection 
of chPMBCs is sialic acid-independent. The interaction of IBV and cellular sialic acid 
remains puzzling: first, IBV does not possess a viral component that destroys sialic 
acid/receptor as for some Betacoronaviruses and all Toroviruses (de Groot, 2006), and 
second, from the IBV glycan array data published by Wickramsinghe et al, the avidity of 
IBV spike protein binding to sialic acid is relatively low compared to influenza virus 
(Wickramasinghe et al., 2011). We speculate that the contribution of sialic acid-IBV 
spike interaction may be secondary for IBV entry, under the assumption that an authentic 
receptor as-yet unidentified, is the primary component in the IBV spike protein-receptor 
complex. The discrepancy between the roles of sialic acid for IBV infection in epithelial 
cells and in chPBMCs can be one feature of the intricate pathogenesis of IBV in the host. 
Our findings on the dispensable role of sialic acid in the IBV infection on chPBMCs 
reveal a more complex virus-receptor/host factor interaction than previously thought.  
DC-SIGN, a widely-expressed C-type lectin receptor on immune cells, has been 
proposed to be an attachment factor for many enveloped viruses, by interacting with the 
viral glycoproteins (Svajger et al., 2011) and recent data has further established that DC-
SIGN has a critical role for both the pathogenesis and interspecies transmission of 
enveloped virus such as bunyaviruses (Lozach et al., 2011). In the coronavirus family, 
human DC-SIGN and/or L-SIGN (a closely related C-type lectin) have been shown to be 
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able to enhance infection of SARS coronavirus, human coronavirus-229E, human 
coronavirus-NL63, as well as feline coronavirus viral entry (Hofmann et al., 2006; Marzi 
et al., 2004; Regan and Whittaker, 2008; Yang et al., 2004). It is reasonable to speculate 
that coronaviruses have evolved to resort to a lectin molecule as a common mechanism 
for systemic spread. Our previous data showed that IBV infectivity in non-permissive cell 
lines can be rescued by introducing human DC-SIGN or L-SIGN(Zhang et al., 2012). 
However, the chicken homolog of DC-SIGN remains unidentified. Interaction with 
receptors or attachment factors plays an important role in determining the species and 
tissue tropism. In our study, we show that infection of PBMCs was inhibited by EGTA, a 
Ca2+ chelating agent, indicating a role for a calcium-dependent C-type lectin. Formal 
proof for the involvement of a C-type lectin could not be obtained, likely due to the lack 
of information on specific avian species of carbohydrates that interact with IBV. 
Coronavirus-induced apoptosis has been documented for a number of viruses in 
the family. For instance, SARS-CoV-infected patients displayed severe organ damage 
that has been suggested to be due to virus-induced apoptosis (Tan et al., 2007). Similar 
gross and microscopic lesions, as well as tissue damage of the respiratory tract and 
kidneys, have also been observed in IBV-infected chickens (Dolz et al., 2011). For IBV, 
apoptosis has been observed in Vero cell cultures infected by laboratory-adapted strain 
Beaudette (Liu et al., 2001). However, there is little information on IBV-induced cell 
death in chicken-specific cell types. In our study, chPBMCs are able to undergo apoptosis 
without IBV replication. However, by blocking acidification of the endosomal 
compartments and arresting IBV in these vesicles, apoptosis was no longer observed. We 
can rationalize that a fusion event in the endosomes after acidification is required for 
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apoptosis and that the IBV-induced apoptosis take place following virus fusion but prior 
to replication.  
Productive infection of monocytes can potentially lead to dissemination of virus 
to distal organs, causing a systemic infection. Programmed cell death can halt the 
productive infection of the monocytes, and can be viewed as a host defense mechanism 
by lowering the viral load in the blood in order to reduce the potential systemic spread of 
viral infection. However, IBV may also utilize apoptosis of monocytes as a strategy to 
evade surveillance that could initiate an immune response against IBV infection. Even 
with a sub-optimal productivity due to premature cell death, it is nevertheless beneficial 
for IBV to spread from the primary site of infection to other organs. Our data suggest that 
IBV infection of peripheral blood derived monocytes/macrophages might be an important 
component in the pathogenesis of IBV in the chicken host and might be critical for viral 
dissemination through the blood to distal organs in vivo. 
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4.1   Abstract 
In non-polarized cell culture model, influenza virus enters host cells via multiple 
endocytic pathways: classical clathri-mediated endocytotic (CME) route, clathrin-, 
caveolae-, independent routes, and macropinocytosis. However, little is known about the 
entry route of influenza virus in differentiated epithelia, in vivo site of infection for 
influenza virus. Here we show that in polarized Madin Darby canine kidney type II 
(MDCK II) cells, influenza virus has a differential utilization for CME pathway and 
requires Eps15 protein for entry. 
 
4.2   Introduction, results and discussion 
Most animal viruses take advantage of the diverse cellular endocytic pathways to 
gain access to the host cells (Sieczkarski and Whittaker, 2002a). After being 
endocytosed, viruses can initiate replication once they penetrate or fuse with the 
endosomal membrane (Marsh and Pelchen-Matthews, 2000). A role of dynamin-
dependent endocytosis of influenza virus entry was demonstrated by examining the effect 
of dominant-negative (DN) dynamin, a small GTPase mediating the scission of clathrin-
coated vesicles from plasma membrane, on influenza virus entry in Mv-1 lung cells (Roy 
et al., 2000). Studies from our group showed that the infectivity of influenza viruses in 
cells expressing a DN mutant of Eps15 (Epidermal growth factor receptor pathway 
substrate), which inhibits clathrin-dependent endocytosis specifically, was not impaired 
(Sieczkarski and Whittaker, 2002b). When chemical inhibitors as well as DN mutant of 
caveolin-1 were used to disrupt caveolae-dependent endocytosis in host cells, influenza 
infectivity was retained as that in untreated cells (Sieczkarski and Whittaker, 2002b). 
These observations lead to the discovery of non-clathrin-dependent, non-caveolae-
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dependent endocytic pathways for influenza virus entry in addition to classical clathrin-
dependent pathway. Recently, with detailed dissection of influenza entry pathways 
independent of dynamin using pharmacological inhibitors, de Vries et al. discovered that 
influenza virus can utilize a macropinocytosis-like route in many cell types (de Vries et 
al., 2011). In the recent advancements of super-resolution fluorescent microscopy, 
individual influenza particle can be tracked in real time without disruption of endocytic 
pathways, a novel technique in discovering redundant or parallel endocytic pathways. 
With the new technique, Epsin1 (Epn1), an adaptor protein that interacts with clathrin, 
adaptors AP2, and Eps15 in clathrin-coated pits, is demonstrated to be an influenza cargo 
specific adaptor for entry via CME pathway in BSC-1 cells (Chen and Zhuang, 2008). 
Examining the dynamics of the endocytic uptake also leads to the conclusions that 
influenza viruses exploit different pathways with the same efficiency and those non-
classical, less-characterized pathways do not act as alternative pathways for influenza 
virus entry.  
Polarized, simple epithelial cells have a plasma membrane that is separated by 
tight junctions into two clearly distinct domains: the apical domain facing the tract lumen 
and the basolateral surface facing the extracellular matrix. Actins, microtubules, as well 
as an array of cellular proteins participate in the organization and maintenance of cell 
polarity. It is well recognized that influenza enters and buds from apical domain of 
MDCK cells (Rodriguez Boulan and Sabatini, 1978). Previous study from our laboratory 
demonstrated that actin microfilaments play different roles in influenza virus infection in 
polarized epithelial cells and non-polarized cells (Sun and Whittaker, 2007). In contrast 
to their dispensable role in viral infection of non-polarized cells, intact actin filaments are 
 99 
obligatory for influenza virus infection in polarized epithelial cells. Since there are 
significant differences between polarized and non-polarized cells with regard to receptor 
distribution, cytoskeletal structure, trafficking events, and mechanism of endocytosis, it is 
possible that our current knowledge of influenza virus entry in non-polarized cells such 
as HeLa, MDCK, BSC-1 cells, does not completely apply to in vivo viral infection, which 
is initiated at the differentiated airway epithelial cells.  This is the first study that 
examined influenza virus entry pathways by pharmacological inhibitors and DN mutant 
proteins in fully polarized MDCK II cells, a robust model for differentiated epithelia 
(Mostov et al., 2003). 
In order to obtain polarized MDCK II epithelial cell culture, MDCK II cells 
(provided by Dr. Colin Parrish, Cornell University) were grown in DMEM media 
supplemented with 10% fetal bovine serum and 1% Penicillin and Streptomycin(Cellgro) 
on 0.4µm semi-permeable Transwell filters (Corning). The semi-permeable filter 
supports allowed nutrients to reach both apical domain and basal domain of the cells. 
Since care must be taken to maintain a true polarized epithelium, polarity was monitored 
by measuring the transepithelial electrical resistance (TEER) of the monolayer cultivated 
on the semi-permeable filter. We used an EVOMX meter along with the electrodes for 
cell culture inserts (World Precise Instruments). Before measurement, culture media was 
changed to fresh warm media for all filter inserts. After being confluent for 3 to 4 days on 
Transwell filter, MDCK II reached an average TEER of 230 ohms.cm2 (Figure 4.1.), 
which was consistent with observations in literature (Shaw, 2002). MDCK cells (ATCC) 
that displayed both fibroblast-like and epithelia-like morphology were used as control 
due to their inability to form tight monolayer. Indeed, the measured TEER of MDCK  
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Figure.4.1. TEER measurements for non-polarized MDCK cells or polarized 
MDCK II cells in this study. MDCK cells or MDCK II cells were grown on 0.4µm 
semi-permeable Transwell filters. TEER of both cell types was measured 3-4 days after 
reaching 100% confluency.  
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cells grown under the same culture conditions of MDCK II cells on Transwell filters was 
10-fold lower than the TEER of those MDCK II cells. (Figure 4.1.) 
To examine the CME pathway, the dominant route used by influenza virus in non-
polarized cell system, we first utilized pharmacological inhibitors that target the CME 
pathways in host cell. Chlorpromazine (CPZ), which prevents clathrin assembly, has been 
widely used to block CME including the study on the entry mechanism of influenza 
viruses in non-polarized cells (Sieczkarski and Whittaker, 2002a). Dynasore has 
inhibitory effect on GTPase activity of dynamin with low cell toxicity (Macia et al., 
2006). Since the discovery of Dynasore, it has been widely used as specific dynamin 
inhibitor for various virus entry studies such as those of VSV, densovirus, HPV type 16 
(Johannsdottir et al., 2009; Schelhaas et al., 2008; Vendeville et al., 2009). CPZ or 
dynasore were used to treat fully polarized MDCK II cells and non-polarized MDCK 
cells for 30 min before infection with influenza virus A/WSN/33 (H1N1), which was 
propagated and titered by plaque assay in MDCK cells. The inhibitor-treated cells were 
then incubated with influenza virus at an MOI of 1 (MDCK) or an MOI of 5 (MDCK II) 
for 1 hour at 37˚C in the presence of inhibitors.  After virus adsorption, the inoculum was 
replaced with fresh media (DMEM supplemented with 2% fetal bovine serum) and 
inhibitor for the incubation duration. At 5 h post infection, cells were fixed with 3% 
paraformaldehyde (PFA) and stained with mouse anti-nucleoprotein (NP) antibody (H16, 
L10-4R5, ATCC) and AlexaFluor 568 secondary antibody against mouse (Molecular 
Probes) for immunofluorescence microscopy. MDCK cells were more sensitive to the 
toxicity of CPZ than MDCK II cells; thus lower concentrations of CPZ were used to treat 
MDCK cells. The quantity of inhibitors used in the treatment did not affect cell viability  
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Figure 4.2. Differential utilization of clathrin-mediated endocytosis pathway by 
influenza virus in non-polarized MDCK cells and polarized MDCK II cells.  MDCK 
cells or MDCK II cells were pretreated with different concentrations of CPZ(A) or 
Dynasore (B)  for 30 minutes at 37°C prior to infection with influenza virus at an MOI of 
1 (MDCK) or an MOI of 5 (MDCK II). At 5h post infection, cells were stained with 
mouse anti-NP antibody and AlexaFluor 568 secondary antibody against mouse for 
immunofluorescence microscopy.  NP-positive cells were quantified from images from 
three independent experiments. Error bar represents standard deviation of the mean. Viral 
infectivity in MDCK cells or MDCK II cells with mock treatments was normalized to 
100%. (C) MDCK cells or MDCK II cells were infected with influenza virus after 
pretreatment with CPZ or Dynasore (DNS). Viral protein M from whole cell lystate was 
analyzed by western blot with mouse anti-M1. Tubulin (Tub) was used as loading 
control.  
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(data not shown). Treatment with CPZ on both MDCK and MDCK II caused a 
substantial reduction on the number of NP expressing cells after influenza infection 
(Figure 4.21A.) However, the Dynasore treatment had a more obvious impact on 
polarized MDCK II cells than their non-polarized counterpart (Figure 4.2B.). This 
evidence indicates a potential role of dynamin in the entry pathway of polarized MDCK 
II cells, while non-polarized MDCK does not depend on the dynamin usage for entry. 
The effect of CPZ and dynamin on the canine kidney cells were further confirmed by 
western blot with infected whole cell lysate with an antibody against viral Matrix protein 
(M2-1C6-4R3, ATCC) (Figure 4.2C).  
The pharmacological approaches mentioned above indicate an important role of 
CME in influenza virus infection in both polarized MDCK II cells and non-polarized 
MDCK cells. However, we wished to examine specific components of the CME pathway. 
Conventional transfection methods with cationic lipid or adenovirus transduction are 
either of low transfection efficiency or not ideal for our study. To overcome the difficulty 
of recombinant protein expression, we used electroporation on monolayer cells as 
described in (Deora et al., 2007). 30 µg/ml of plasmid DNA was mixed with 
electroporation buffer (Eppendorf) and was delivered using an electrode (CUY512-5, 
Nepagene) connected to ECM 830 electroporation system (BTX Instrument). We 
electroporated wild type (WT) or dominant negative (DN) constructs of Dynamin 2 
(Figure 4.3A), Eps15 (Figure 4.3B), or Epn1 (Figure 4.3C) into fully polarized MDCK II 
cells and infected MDCK II cells with influenza virus at a MOI of 5 after 18 h post 
electroporation (Table 4.1). Cells were then fixed and stained for confocal microscopy 
after 5 h of infection. Expression of DN form of Dynamin 2 or Epn1 had reduced  
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Table 4.1.  List of plasmid constructs used  
 
Protein Construct Source 
Dynamin 2 
Dynamin2-GFP (WT) 
Dynamin2-GFP-K44A (DN) 
Dr. Mark McNiven, Mayo Clinic Cancer Center 
 
Eps15 
Eps15-DIIIΔ2-GFP (WT) 
Eps15-Δ95/295-GFP (DN) 
Dr. Jennifer Lippincott-Schwartz, NIH 
 
Epsin1 (Epn1) 
Epsin1-ECFP 
Epsin1ΔUIM-ECFP 
Dr. Xiaowei Zhuang, Harvard University 
 
Caveolin 1 
Caveolin1-GFP (WT) 
Caveolin1-GFP (DN) 
Dr. Ari Helenius, ETH Zürich 
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Figure 4.3. Eps15 is required for influenza virus infection on polarized MDCK II 
cells. MDCK II cells were polarized on Transwell filters for 3-4 days and then were 
electroporated with either wild type (WT) or dominant negative (DN) constructs of 
Dynamin2 (A), Eps15 (B), or Epsin1 (C). 18 h post electroporation, cells were infected 
with influenza virus at MOI of 10. At 5 h post infection, cells were fixed and stained with 
mouse anti-NP antibody for confocal microscopy. (D) Both transfected and infected cells 
were scored and quantified from images from three independent experiments. Student’s t 
test was used to calculate the statistical significance between differences of % infected 
cells in cells expressing WT and DN proteins. * indicates p<0.05. 
* 
* * 
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percentage of GFP or EYFP expressing cells that were positive for viral NP expression, 
comparing to the control WT version of the respective construct (Figure 4.3D). However, 
unlike in non-polarized cell such as HeLa cells described in previous study (Sieczkarski 
and Whittaker, 2002b), Eps15-Δ95/295-GFP DN construct expression in MDCK II cells 
greatly reduced the percentage of cells infected with influenza virus and expressing viral 
NP, comparing to its WT counterpart Eps15-DIIIΔ2-GFP expressing cells. 
Recently influenza virus has been shown to be able to enter host cell via 
macropincytosis pathway (de Vries et al., 2011; Rossman et al., 2012). To examine 
whether influenza virus can also utilize macropinocytosis in polarized MDCK II cells, we 
used 5-ethylisopropyl amiloride (EIPA; Sigma), a macropinocytosis inhibitor that Inhibits 
Na+/H+ exchanger activity to treat the canine kidney cells before infecting with influenza 
virus (Mercer and Helenius, 2009). By examination of viral protein M1 in whole cell 
lysate using western blot analysis, we found that neither MDCK cells nor MDCK II cells 
were significantly inhibited by EIPA, regardless of drug treatment concentrations (Figure 
4.4). Our data suggest that similar to non-polarized MDCK cells, there exist redundant 
entry pathways (presumably CME) in polarized MDCK cells and macropinocytosis is not 
a preferential major pathway utilized by influenza virus. 
  In non-polarized cell system, influenza has been shown to enter host cells via 
caveolae-independent entry routes (Sieczkarski and Whittaker, 2002b). To examine 
whether influenza virus enters polarized MDCK II cells via caveolae-independent entry 
pathway as in previous studies on non-polarized cells, we first treated the MDCK or 
MDCK II cells with different concentrations of caveolae-inhibiting drugs such as Methyl-
β-cyclodextrin (MBCD) and nystatin. As revealed by expression of viral protein M1 on  
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Figure 4.4. Macropinocytosis inhibitor does not affect influenza virus infection in 
MDCK II cells. Polarized MDCK II cells were treated with EIPA before infection with 
influenza virus.Viral protein M from whole cell lystate was analyzed by western blot with 
mouse anti-M1. Tubulin (Tub) was used as loading control. 
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western blot, treatment with high concentrations of MBCD was able to inhibit both 
polarized MDCK II cells and non-polarized MDCK cells (Figure 4.5A). In contrast, 
nystatin did not have an inhibitory effect on either cell type. To examine the caveolar-
mediated pathway more specifically in polarized MDCK II cells, we electroporated GFP-
tagged Caveolin-1 WT or DN plasmids into polarized MDCK II cells before infection 
with influenza virus. Caveolin-1 is a major structural protein in the caveolae. Using 
confocal microscopy, both Cav1 WT and Cav1 DN expressing cells were able to be 
infected by influenza virus as shown by the positive signal of viral NP in the transfected 
cells (Figure 4.5C, 4.5D). The discrepancy in influenza virus infectivity in MDCK II cell 
after treatment with MBCD and with nystatin may be due to the discrete modes of action 
by the two drugs: MBCD inhibition on influenza virus entry in both MDCK and MDCK 
II cells was not by inhibiting caveolae-dependent endocytosis , by altering the structure of 
cholesterol-rich domain in plasma membrane. A similar observation was also described 
in SARS-coronavirus entry studies (Li et al., 2007b; Wang et al., 2008). Taken together, 
our data demonstrated that, similar to non-polarized MDCK cells, influenza virus does 
not enter polarized MDCK II through caveolae-dependent endocytosis. 
To our knowledge, this is the first time that endocytic pathways employed by 
influenza virus in a fully polarized epithelial cell system grown on Transwell filter were 
examined. Polarized epithelial cells are usually refractory to transfections and more 
difficult to work with compared to non-polarized cells. Components in the CME pathway 
have shown to be regulators of cell polarity (Deborde et al., 2008; Shivas et al., 2010). To 
avoid DN cellular proteins disrupting formation of proper cellular polarity, we chose to 
introduce the DN constructs to the MDCK II cells after the cells formed a tight  
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Figure 4.5. Influenza virus does not enter polarized MDCK II cells via caveolae-
mediated endocytosis. MDCK cells or MDCK II cells were either pretreated with 
MBCD (A) or nystatin (B) for 30 min before infected with influenza virus. Viral protein 
M was analyzed with mouse anti-M1 antibody on western blot from infected whole cell 
lysates. (C) Polarized MDCK II cells were infected with influenza virus after 
electroporation with Caveolin-1 (Cav1) WT plasmid or Cav1-DN plasmid and were 
analyzed with confocal microscopy with mouse anti-NP antibody. (D) Both transfected 
and infected cells were quantified from confocal images from three independent 
experiments.  
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monolayer and were fully polarized. Conventional transfection method utilizing cationic 
lipid often yields low transfection efficiency in polarized epithelial cells (data not 
shown). Adenovirus transduction to introduce recombinant protein into polarized 
epithelia is another frequently used method. However, adenovirus can induce 
macropinocytosis and other undesirable signaling events after gaining access into host 
cell (Amstutz et al., 2008; Hayashi and Hogg, 2007; Sirena et al., 2004; Wickham et al., 
1993). 
Dynamin2 and Epn1 DN proteins had a small reduction on the percentage of 
MDCK II cells infected with influenza virus. This may be due to a masking effect by 
other endocytic pathways that the virus particles enter through while CME pathway was 
inhibited (at least partially) by Dynamin 2 or Epn1 DN proteins. Unexpectedly, a large 
portion of polarized MDCK II cells expressing Eps15 DN were not able to be infected by 
influenza virus (Figure 4.3D) Eps15 is an adaptor protein that interacts with Epsin1, 
AP180, and synaptojanin via the Eps homology (EH) domains and recruits cargo adaptor 
protein AP-2 to plasma membrane (Salcini et al., 1997). The inhibitory effect of Eps15-
Δ95/295 DN protein on influenza virus entry in polarized MDCK II cells suggests that 
Eps15 plays an important role for influenza virus entry at CME pathway. The 
requirement of functional Eps15 for influenza virus at clathrin-coated pit could involve a 
different adaptor protein that is associated with Eps15. 
 In non-polarized cell system, it is well documented that influenza virus enters host 
cells through CME (Chen and Zhuang, 2008; Sieczkarski and Whittaker, 2002b). Other 
entry routes such as clathrin, caveolae-independent routes, and macropinocytosis have 
also been described (de Vries et al., 2011; Sieczkarski and Whittaker, 2002b). In addition, 
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influenza infectious entry utilized different endocytic routes in different non-polarized 
epithelial cell types(De Conto et al., 2010). By using pharmacological and molecular 
approaches, our study demonstrated that influenza virus enters polarized MDCK II cells 
preferentially via clathrin-dependent, caveolae-independent route. The utilization of 
endocytic pathway was similar to the route observed in non-polarized MDCK cells. 
Under the treatment of CME inhibitors such as CPZ and dynasore, there was a portion of 
MDCK II cells that allowed influenza virus gains entry to the cells (Figure 4.2A, 4.2B). 
In addition, we observed that a significant percentage of these cells expressed both Eps15 
DN and viral NP (Figure 4.2D), indicating that the influenza virus was able to overcome 
the effect of dysfunctional Eps15 protein in polarized MDCK II cells. These data implied 
that there exist other endocytic pathways that are utilized by influenza virus to gain entry 
into the polarized cells. 
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CHAPTER 5 
Summary and conclusions 
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 A typical enveloped virus life cycle is initiated with binding to a receptor or 
attachment factor on the host cell surface. Then the virus particle is internalized by a cell-
driven process-endocytosis into cellular compartments such as endosomes. Upon the 
acidification of the endosome, this enveloped virus can fuse its viral membrane with host 
vesicle membranes. The genetic material, e.g. viral RNA complexes, can be deposited 
into the cytosol for subsequent viral replication. My thesis research, which studied IBV 
and influenza virus, has focused on the first two steps of the viral entry processes: 
attachment and endocytosis. 
 
Attachment: receptor determinants of IBV 
Attachment of virus to host cells and receptor determinants of the prototype avian 
coronavirus IBV in non-permissive and permissive cells were investigated in this thesis. 
Even though the putative receptor for IBV is not identified, sialic acid, a terminal sugar 
on glycoproteins or glycolipids, is proposed to be an attachment factor for IBV (Winter et 
al., 2006). Intriguingly, IBV is able to infect many different tissues or organs in the host 
chicken; yet IBV is unable to infect any cells from other animal species than chicken. The 
sialic acid binding pattern in multiple chicken organs is implicated in pathogenesis in the 
host, but the correlation of binding cannot explain the limited susceptibility of IBV to 
non-chicken cells since sialic acid is ubiquitously expressed in animal tissues 
(Wickramasinghe et al., 2011). The lack of knowledge of IBV receptor leaves a big gap 
in our understanding of the relatively wide chicken tissue tropism and strict species 
tropism of IBV. When DC-SIGN, a human C-type lectin that may resemble a chicken 
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homolog lectin, was expressed by either stable transfection or transient transfection in 
mammalian cell lines, I found that IBV infection was rescued in these cell lines, 
suggesting a potential role for C-type lectin as receptor or attachment factor for IBV. 
After neuraminidase treatment, which removed most of the sialic acid from the cell 
surface, I also demonstrated that the C-type lectin rescue of IBV infection was not 
dependent on the level of sialic acid on the cell surface. In addition, I examined whether 
sialic acid also plays a role in IBV infection in chicken PBMCs, host cells that potentially 
harbor the authentic proteinaceous receptor for IBV. Unexpectedly, I found that the 
established attachment factor sialic acid did not play a critical role in the IBV infection in 
PBMC. Overall, the data suggest that, sialic acid may be dispensable or may play a lesser 
role in virus-receptor complex formation in the presence of a potential high-affinity 
receptor molecule e.g. DC-SIGN. 
The IBV virus-receptor complex is more intricate than previously thought. Based 
on my data and previous published data from the literature, there can be several possible 
scenarios for the interaction of IBV virus-receptor complex, assuming there exists an 
unknown proteinaceous receptor for IBV (Chu et al., 2007; Wickramasinghe et al., 2011). 
In the respiratory, alimentary, and reproductive tract, IBV may rely heavily on the 
attachment factor sialic acid to enter host epithelial cells. This hypothesis is supported by 
the evidence in a report published by Winter and coworkers as well as my data that IBV 
is not able to enter epithelial cells after sialic acid was removed by neuraminidase 
(Winter et al., 2006). However, in cells (non-epithelial, possibly immune cells) 
expressing C-type lectins that are similar to human DC-SIGN or L-SIGN, IBV may be 
able to enter without the help of sialic acid and C-type lectins can be the sole receptor 
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allowing IBV entry. The third scenario is the one that was observed in chicken 
monocytes:  an unknown proteinaceous receptor is highly expressed in chicken 
monocytes and sialic acid plays a minor role in the virus-receptor complex. 
The discovery of the capacity of a C-type lectin to allow IBV infection in non-
avian cells may shed light on future research on IBV receptor studies. However, the 
authentic host receptor for IBV is yet to be determined. My studies on the C-type lectin 
rescue of IBV infection in non-permissive mammalian cells suggested that C-type lectin 
could be a promising candidate for IBV receptor. C-type lectin serves as a receptor or an 
attachment factor for numerous animal viruses, including viruses in the coronavirus 
family (Han et al., 2007; Regan and Whittaker, 2008). However, my attempt to identify a 
chicken homolog of human DC-SIGN or L-SIGN has not been successful and it is 
unclear what chicken molecule that resembles the said C-type lectin can allow IBV entry 
in chicken cells. Initially, a BLAST analysis with human, monkey, dog DC-SIGN amino 
acid sequence in the chicken genome database yielded several potential candidates. The 
most promising candidate -chicken hepatic lectin (CHL) was cloned into the same 
expression vector as human DC-SIGN (pCDNA 3.1) and was expressed in non-
permissive cells (3T3 cells). However, IBV infection could not be rescued in these cells. 
Although CHL was considered structurally as a chicken equivalent of DC-SIGN of 
human and other species (Lin et al., 2009), the carbohydrate binding specificity of CHL 
and DC-SIGN are different: DC-SIGN binds to high mannose and/or fucose residues on 
glycoproteins (Guo et al., 2004) while CHL is specific for terminal N-acetyl-glucosamine 
on glycoproteins (Kawasaki and Ashwell, 1977). Since the C-type lectin interaction with 
IBV may be due to the binding of a carbohydrate recognition domain of the lectin to the 
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sugar moiety on the spike protein, the discrepancy between the binding specificities of 
two C-type lectins could be the reason why CHL fails to rescue IBV infection. 
Aminopeptidase N (APN) was considered as a universal receptor for 
Alphacoronaviruses (Tusell et al., 2007). There are speculations that APN is a possible 
receptor for IBV (Miguel et al., 2002). To test whether APN can act as a receptor for 
IBV, chicken APN was expressed in 3T3 cells. However, over-expression of the chicken 
homolog of APN did not rescue infection by IBV. This suggests that IBV cannot use 
chicken APN either as a sole receptor or as a receptor within the receptor-virus complex. 
Future directions 
There were several observations during my research on IBV projects that are very 
interesting and may be worthwhile for follow-up. First, infection in DC-SIGN stable cell 
lines (such as 3T3-DCSIGN cells) was not a productive infection. In chicken kidney 
cells, the typical cells used for IBV infection in laboratories, IBV usually caused 
cytopathic effect in the infected cells (Liu et al., 2001). The kidney cells then produced 
infectious virions approximately 24-48 h post infection. However, no infectious virions 
were produced in IBV-M41 infected 3T3-DCSIGN cells 24 h post infections, although I 
observed cytopathic effect about 12 h post infection. I could not see any IBV infection 
(by immunofluorescence assay) in new cells with supernatant from infected 3T3-
DCSIGN cells. Moreover, I could detect little of the viral protein N in the infected cell 
supernatant using western blot. The level of viral protein in the infected 3T3-DCSIGN 
cell supernatant was similar to that of the basal level of supernant from the infected 3T3 
cells. There are a couple of possible explanations for non-productive infection in the 3T3-
DCSIGN cells. Although I observed high expression of the viral protein spike in the 
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infected cells, it is possible that the progeny virions were associated with the infected 
cells and were not released into the cell culture media. To address the possibility, I used a 
syringe with a 26g5/8 needle to lyse the cells post infection to allow virions to dissociate 
from infected cells. However, the lysis with mechanical tearing did not yield any 
infectious virions. It is also possible that progeny virus associated with DC-SIGN 
molecules with high affinity thus the progeny virions remained tightly attached to the 
infected cell surface or cell debris. This possibility had not yet been addressed. Scanning 
electron microscopy of the infected 3T3-DCSIGN cell surface can be used to visualize 
potential virions attached to the cell surface. Other possibilities for an unknown block in 
assembly and budding of IBV in these murine cells cannot be ruled out. It will be very 
interesting to find out the requirement for IBV to replicate in mammalian cells such as 
3T3 cells. IBV Beaudette, a strain that was derived from M41 and has high sequence 
homology to M41, is able to replicate and to produce progeny virions in Vero cells, a cell 
type that is deficient in interferon. It is interesting to see whether interferon can play a 
hindering factor for IBV M41 to produce progeny virus in the murine 3T3 cells. 
The second interesting observation was that IBV Beaudette could not infect 
chicken monocytes. To ensure the virus prep was viable, the same Beaudette that I used 
to infect chicken monocytes was able to infect BHK-21 (hamster cells) shown by 
immunofluorescence for viral protein spike.  Then I performed a binding assay to further 
examine the infection block in the chicken monocytes. M41 or Beaudette was allowed to 
bind to monocyte surface on ice and then was detected by immunofluorescence and flow 
cytometry of viral spike protein.  M41 bound to monocytes in a virus concentration 
dependent manner as expected. However, Beaudette was not able to bind to the 
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monocytes. This observation is intriguing and leads to my hypothesis that Beaudette uses 
a different receptor than M41. The difference in the ability of M41 and Beaudette to 
infect chicken monocytes may be an important factor for the drastic difference of the IBV 
pathogenesis between these two viruses. M41 is pathogenic in chickens while Beaudette 
does not cause any diseases (Saif, 2003b). The spike protein of M41 and Beaudette has 
96% sequence identity. S1 subunit is responsible for receptor-binding (Cavanagh and 
Davis, 1986; Koch et al., 1990). Using sequence alignment of Beaudette and M41 spike 
protein amino acid sequences, I found that there are 27 amino acid differences between 
the two viruses in the S1 subunit. It is possible that by mutagenesis of unique M41 amino 
acid and examining the abolished binding effect on chicken monocytes we will be able to 
find key residues for true receptor binding.  
IBV entry in chicken kidney cells may reply heavily on sialic acid attachment. 
The true receptor—IBV interaction, which is masked by the sialic acid-IBV interaction, 
may be difficult to identify. Thus, using chicken kidney cells as a source for receptor 
identification or isolation can be problematic since IBV uses sialic acid as attachment in 
chicken kidney cells (Winter et al., 2006). At the start of my research on IBV, I attempted 
to identify the IBV receptor by a pull-down method or a virus-overlay blot method using 
chicken kidney cells as a source of receptor. However, the attempts were not successful 
and only inconclusive results were obtained. In the future, to look for the putative 
proteinaceous receptor for IBV, chicken monocytes will be an excellent source for the 
receptor. Virus overlay blot method is an excellent way to identity virus receptor. It will 
be useful to remove sialic acid beforehand to reveal the interactions between virus spike 
and cellular receptor.   
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Endocytosis 
The second focus of my thesis research was endocytosis of virus in host cells. The 
endocytosis of IBV in chicken peripheral-blood monocytes and endocytosis of influenza 
virus in polarized MDCK epithelial cells were investigated in this thesis. Enveloped 
viruses usually employ sophisticated, receptor-mediated endocytosis pathways to gain 
entry into host cells, although endocytosis is a normal cellular activity for uptake of 
nutrients. Many studies on virus entry pathways rely on continuous cell lines that are easy 
to cultivate and to manipulate. However, viruses can utilize distinct endocytic pathways 
in different cell types (Choi et al., 2005; De Conto et al., 2010; Li et al., 2007b; Pu and 
Zhang, 2008; Wang et al., 2008). In my work described here, endocytosis pathways were 
investigated in primary cells (chicken monocytes) and differentiated cells (polarized 
MDCK cells). This work provides an increased understanding of the uptake of 
coronavirus or influenza virus in host cells.  
 
IBV endocytosis 
Previous members of the Whittaker laboratory demonstrated that IBV Beaudette 
enters BHK-21 cells by low-pH dependent endocytic pathways (Chu et al., 2006a; Chu et 
al., 2006b). In my study here, using chemical inhibitors treatment, a clear description can 
be made of the internalization of IBV field strain M41 in host cells: primary chicken 
monocytes. I found that IBV did not use a clathrin-mediated endocytic pathway in 
monocytes since viral infection was not inhibited by treatment with dynasore or 
hypotonic solution. As a control, Tfn (transferrin) uptake was abolished by treatment with 
the clathrin-mediated endocytosis inhibitors. To further investigate the pathway that IBV 
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employs to enter chicken monocytes, I also used cholesterol-depleting inhibitors to treat 
the cells before infection with IBV. A reduction of infection of IBV in monocytes after 
treatment of MBCD and nystatin indicated a potential role of cholesterol in the uptake of 
IBV in these cells. Macropinocytosis inhibitor EIPA inhibited IBV infection in chicken 
monocytes. Treatment with the actin-disrupting agent cytochalasin D treatment also 
decreased IBV infection in monocytes, providing supporting evidence for the important 
role of macropinocytosis in IBV entry. It is not surprising that macropinocytosis is used 
as a dominant route of entry by IBV in monocyte since peripheral-blood derived 
monocytes constitutively internalize foreign antigens by macropinocytosis as their innate 
immune function (Mercer and Helenius, 2009). 
 
Influenza endocytosis 
Influenza virus entry pathways are well characterized among the enveloped 
viruses. However, it is unclear whether the entry pathways in cells other than non-
polarized cells is similar to what was known. By using chemical inhibitor and expression 
of dominant negative acting proteins, I found that influenza virus enters polarized MDCK 
II cells predominantly by clathrin-mediated endocytosis pathway. Similar to non-
polarized cells, influenza virus does not use caveolae-mediated endocytosis as an entry 
route in polarized MDCK II cells.  
One experiment that would be interesting to append to this particular study is to 
examine the effect of inhibitors or dominant negative proteins with another known 
cellular protein or a virus that utilizes a certain endocytic pathway. Traditionally, Tfn 
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uptake is used as a control to assess the function of the clathrin-mediated pathway, and 
cholera toxin (CTX) uptake is used as a control for caveolae-mediated endocytosis. In the 
3-dimensional polarized cell system, the apical domain and basolateral domain have 
distinct receptor distributions and endocytosis machineries, which are not taken into 
consideration in the flat, 2-dimensional non-polarized cell system. The uptake of Tfn and 
CTX takes place in the basolateral domain of polarized epithelial cells (Gottlieb et al., 
1993; Torgersen et al., 2001). In contrast, influenza virus is known to infect and bud from 
the apical domain of polarized epithelial cells (Rodriguez Boulan and Sabatini, 1978). 
Evaluation of basolatoeral domain endocytosis after manipulation of the cells may not 
provide precise information for apical domain endocytosis. Thus, conventional uptake 
assays with Tfn and CTX to assess functions of endocytic pathways are not suitable for 
influenza virus. Well-characterized viruses such as SFV (Semliki forest virus) or VSV 
(vesicular stomatitis virus) are usually used as control virus for the clathrin-dependent 
pathway (Helenius et al., 1980; Johannsdottir et al., 2009; Sun et al., 2005). However, 
examination of virus entry pathways in polarized cell system is a novel study field, no 
information is available on endocytic pathways of “reference” viruses. Instead, I chose to 
compare the virus infectivity in polarized MDCK II cell to its non-polarized counterpart 
with same manipulations. Both polarized MDCK II cells and non-polarized MDCK cells 
were derived from the same origin (ATCC). The two types of MDCK cells differ in their 
morphology due to clonal selection (ManWarren et al., 1997; Nichols et al., 1986). In 
addition, cultivation of MDCK II cells in semi-permeable Transwell filter ensures proper 
formation of polarity (Handler, 1983). 
In the experiment where dominant-negative proteins (Dyn2, Eps15, Epsin1) 
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implicated in the clathrin-dependent pathways were introduced into polarized MDCK II 
cells, I found that influenza virus infectivity was reduced. The data suggested that 
influenza virus used clathrin-dependent endocytosis in polarized MDCK II cells. It is 
clear that there is a difference in the level of reduction of influenza virus infectivity in 
cells expressing these DN proteins. The influenza virus entry was slightly reduced in 
Dyn2 DN expressing MDCK II cells. It is possible that influenza also uses a dynamin-2 
independent pathway to enter the cells; thus a large portion of influenza virus can still 
enter cells overexpressing DN Dyn2 protein.  Eps15 DN expressing MDCK II cells 
revealed a great reduction on influenza virus entry. This is unexpected since in non-
polarized cells e.g. HeLa cells, influenza virus entry is not inhibited by Eps15 DN 
expression (Sieczkarski and Whittaker, 2002b). The data presented here suggest that 
influenza virus has a different of utilization of components in the clathrin-mediated 
endocytosis pathway. Influenza virus entry in polarized MDCK II cells, instead of using 
Epsin1 as a cargo-specific adaptor as in non-polarized cells, may depend on a different 
adaptor (e.g. AP-2) that is associated with Eps15, since Eps15 does not directly bind to 
influenza virus (Chen and Zhuang, 2008). Nevertheless, an alternative explanation of the 
different levels of reduction of influenza infectivity in cells expressing the DN protein of 
Dyn2, Eps15, Epsin1 can be the different levels of knock-down effect by the DN 
proteins.  
 MDCK cells are a robust and widely used system to study cellular polarity 
(Mostov et al., 2003). Polarized MDCK cells are used here as a model for the 
differentiated epithelial cells in the airway, where in vivo influenza infection occurs. My 
study here is an initial step to investigate the entry mechanisms of influenza virus in 
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polarized epithelial cells. Future studies will need to use more indicative models of in 
vivo infection. Many literature studies have focused on influenza infection on human 
airway epithelial cells or human bronchial/tracheal cells (Ilyushina et al., 2012a; 
Ilyushina et al., 2012b; Oshansky et al., 2011). The primary cells such as human 
bronchial cells have limited doublings in laboratory culture and are more difficult to work 
with than continuous cell lines such as MDCK cells. Nevertheless, these human polarized 
cells are usually cultured in similar conditions to MDCK II cells. The chemical and 
molecular approaches described in the study here can be applied to the human polarized 
epithelial cells to investigate the influenza entry pathways. In the past, manipulations of 
polarized cells especially introduction of dominant negative plasmids into fully polarized 
cells were problematic (Sun and Whittaker, 2007). My study here demonstrated that the 
protocol difficulties were overcome by using electroporation on monolayer cells. This 
particular method not only allows efficient expression of recombinant proteins from 
plasmid DNA but also is superior over other transfection methods such as nucleofection 
and viral transduction.  
Conclusion 
 Although there are still many unanswered questions remaining on the topic of my 
thesis research, overall, my work has provided a better understanding of reeptor 
determinants and the entry pathways of two respiratory viruses: IBV and influenza virus. 
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